ANNEX 3 Linies.pdf - FundaciÃ³ Institut d'InvestigaciÃ³ en CiÃ¨ncies de ...

ANNEX 3 

Relació detallada de la producció 

científica per línies prioritàries i tipus 

d’investigació 

Relación detallada de la producción 

científica por líneas prioritarias y tipo 

de investigación 

Detailed list of the scientific 

production according the priorized 

areas and type of research

PROJECTES PUBLICACIONS 

FACTOR 

D'IMPACTE 

Infecto-Immuno Inflamació 62 210 962,714 

Bàsica 26 57 366,061 

Clínica 9 119 462,189 

Traslacional 27 34 134,464 

Càncer 13 102 495,044 

Bàsica 2 19 141,231 

Clínica 5 61 235,173 


Epidemiologia Clínica i Molecular. Salut Pública. 

Salut Internacional 

12 47 188,357 

Bàsica -- 4 5,233 

Clínica 10 42 178,998 


Tecnologia Aplicada a la Biomedicina 

(Biotecnologia, Bioenginyeria i Bioinformàtica) 

4 37 113,95 

Bàsica -- 14 30,184 

Clínica -- 12 39,259 


Innovació Clínica-Terapèutica i Serveis Sanitaris 14 135 366,436 

Bàsica 1 4 5,894 

Clínica 12 125 339,008 


105 531 2126,501 

Pàgina 2 de 67


INFECTO-INMUNO 

INFLAMACIÓN 

Publicacions 

INVESTIGACIÓ BÀSICA 

Adams GG, Uddin A, Vives-Pi M, Pujol-Borrell R, James RFL. 

Characterisation of the NES2Y cell line and its use in the production of human glucose-responsive insulin producing (hGRIP) cell 

lines 

ISLETS 2009; 1:117-123 

Alonso N, Martínez-Arconada MJ, Granada ML, Soldevila B, Cantón A, Mate JL, Sanmartí A, Martínez-Cáceres EM. 

Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis. 

ENDOCRINE 2009-JUN; 35 (3): 420-428 

IF: 1,899 

Alonso, N; Soldevila, B; Sanmarti, A; Pujol-Borrell, R; Martinez-Caceres, E 

Regulatory T cells in diabetes and gastritis 

AUTOIMMUN REV 2009-JUL; 8 (8): 659-662 

IF: 6,368 

Ballana, E; Pauls, E; Senserrich, J; Clotet, B; Perron-Sierra, F; Tucker, GC; Este, JA 

Cell adhesion through alpha V-containing integrins is required for efficient HIV-1 infection in macrophages 

BLOOD 2009-feb-05; 113 (6): 1278-1286 

IF: 10,555 

Beyer, K; Domingo-Sabat, M; Ariza, A 

Molecular Pathology of Lewy Body Diseases 

INT J MOL SCI 2009; 10:724-745 

IF: 1,387 

Bihl, F; Berger, C; Chisholm, JV; Henry, LM; Bertisch, B; Trojan, A; Nadal, D; Speck, RF; Flepp, M; Brander, C; Mueller, NJ 

Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma 

AIDS 2009-SEP 10; 23 (14): 1918-1922 

IF: 4,909 

Brainard, DM; Seung, E; Frahm, N; Cariappa, A; Bailey, CC; Hart, WK; Shin, HS; Brooks, SF; Knight, HL; Eichbaum, Q; Yang, YG; 

Sykes, M; Walker, BD; Freeman, GJ; Pillai, S; Westmoreland, SV; Brander, C; Luster, AD; Tager, AM 

Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected 

Humanized BLT Mice 

J VIROL 2009 jul-15;83:7305-7321 

IF: 5,150 

Brander, C; Marincola, FM 

AAAS joins the Translational Medicine family 

J TRANSL MED 2009-MAY 7; 7 

IF: 3,407 

Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, 

Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S. 

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins 

PLOS ONE 2009 Aug 19;4(8):e6687. 

IF: 4,351 

Caceres, N; Tapia, G; Ojanguren, I; Altare, F; Gil, O; Pinto, S; Vilaplana, C; Cardona, PJ 


Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models 

TUBERCULOSIS 2009-MAR; 89 (2): 175-182 

IF: 2,536 

Caporuscio, F; Tafi, A; Gonzalez, E; Manetti, F; Este, JA; Botta, M 

A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120- 

CD4 protein-protein interactions 

BIOORG MED CHEM LETT 2009; 19:6087-6091 

IF: 2,650 

Clotet-Codina, I; Bosch, B; Senserrich, J; Fernandez-Figueras, MT; Pena, R; Ballana, E; Bofill, M; Clotet, B; Este, JA 

HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection 

ANTIVIR RES 2009 Jul;83(1):94-8. Epub 2009 Apr 5 

IF: 3,612 

Coupling retroviral production with a selectable event: selection of transcription factors that modulate γ-globin expression. 

Ulrich Tschulena, Kenneth R. Peterson, Beatriz Gonzalez, Halyna Fedosyuk & Carlos F. Barbas III. 

NAT STRUCT MOL BIOL 2009; Nov;16(11):1195-9. 

IF: 12,273 

Dalmau, J; Puertas, MC; Azuara, M; Marino, A; Frahm, N; Mothe, B; Izquierdo-Useros, N; Buzon, MJ; Paredes, R; Matas, L; Allen, 

TM; Brander, C; Rodrigo, C; Clotet, B; Martinez-Picado, J 

Contribution of Immunological and Virological Factors to Extremely Severe Primary HIV Type 1 Infection 

CLIN INFECT DIS 2009-JAN 15; 48 (2): 229-238 

IF: 8,195 

Darwich, L; Coma, G; Pena, R; Bellido, R; Blanco, EJJ; Este, JA; Borras, FE; Clotet, B; Ruiz, L; Rosell, A; Andreo, F; Parkhouse, RME; 

Bofill, M 

Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin 

(IL)-12 plus IL-18 

IMMUNOLOGY 2009-MAR; 126 (3): 386-393 

IF: 3,276 

Davalos, A; de la Pena, G; Sanchez-Martin, CC; Guerra, MT; Bartolome, B; Lasuncion, MA 

Effects of red grape juice polyphenols in NADPH oxidase subunit expression in human neutrophils and mononuclear blood cells 

BRIT J NUTR 2009; 102:1125-1135 

IF: 3,446 

Del Castillo JM, García-Martín MC, Arias-Díaz J, Giné E, Vara E, Cantero JL. 

Antiapoptotic effect of tacrolimus on cytokine-challenged human islets. 

CELL TRANSPLANT 2009;18(10):1237-46. Epub 2009 Aug 5. 

IF: 5,126 

Dominguez, J; De Souza-Galvao, M; Ruiz-Manzano, J; Latorre, I; Prat, C; Lacoma, A; Mila, C; Jimenez, MA; Blanco, S; Maldonado, J; 

Altet, N; Ausina, V 

T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and 

after antituberculosis treatment 

DIAGN MICR INFEC DIS 2009-JAN; 63 (1): 43-51 

IF: 2,451 

Fernàndez-Busquets X, Ponce J, Bravo R, Arimon M, Martianyez T, Gella A, Cladera J, Durany N. 

Modulation of Amyloid beta Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate. 

CURR ALZHEIMER RES 2009 Dec 31. [Epub ahead of print] 

IF: 4,971 

Fernandez-Hernando, C; Yu, J; Suarez, Y; Rahner, C; Davalos, A; Lasuncion, MA; Sessa, WC 

Genetic Evidence Supporting a Critical Role of Endothelial Caveolin-1 during the Progression of Atherosclerosis 

CELL METAB 2009; 10:48-54 

IF: 17,350 

Garcia-Nunez, M; Pedro-Botet, ML; Ragull, S; Sopena, N; Morera, J; Rey-Joly, C; Sabria, M 

Cytopathogenicity and molecular subtyping of Legionella pneumophila environmental isolates from 17 hospitals 


EPIDEMIOL INFECT 2009; 137:188-193 

IF: 2,365 

Gemma Òdena, Eduard Cabré, Amparo Galan, Ramon Planas and Ramon Bartolí. 

Administration of Lactobacillus fermentum CECT 5716 does not prevent intestinal bacterial translocation in ascitic cirrhotic rats 

EUR J CLIN NUTR 2009 (4) e265–e269 

IF: 3,072 

Gil O, Díaz I, Vilaplana C, Tapia G, Díaz J, Fort M, Cáceres N, Pinto S, Caylà J, Corner L, Domingo M, Cardona PJ. 

Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs. 

PLOS ONE 2009; 5(4): e10030. doi:10.1371/journal.pone.0010030 

IF: 4,351 

Gil V, Bichler Z, Lee JK, Seira O, Llorens F, Bribian A, Morales R, Claverol-Tinture E, Soriano E, Sumoy L, Zheng B, Del Río JA. 

Developmental Expression of the Oligodendrocyte Myelin Glycoprotein in the Mouse Telencephalon. 

CEREB CORTEX 2009 Nov 5. [Epub ahead of print] 

IF: 6,979 

Grau-Lopez, L; Raich, D; Ramo-Tello, C; Naranjo-Gomez, M; Davalos, A; Pujol-Borrell, R; Borras, FE; Martinez-Caceres, E 

Myelin peptides in multiple sclerosis 

AUTOIMMUN REV 2009-JUL; 8 (8): 650-653 

IF: 6,368 

Harrison, KD; Miao, RQ; Fernandez-Hernando, C; Suarez, Y; Davalos, A; Sessa, WC 

Nogo-B Receptor Stabilizes Niemann-Pick Type C2 Protein and Regulates Intracellular Cholesterol Trafficking 

CELL METAB 2009; 10:208-218 

IF: 17,350 

Izquierdo-Useros, N; Naranjo-Gomez, M; Archer, J; Hatch, SC; Erkizia, I; Blanco, J; Borras, FE; Puertas, MC; Connor, JH; Fernandez- 

Figueras, MT; Moore, L; Clotet, B; Gummuluru, S; Martinez-Picado, J 

Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway 

BLOOD 2009-març-19; 113 (12): 2732-2741 

IF: 10,555 

Kawashima, Y; Pfafferott, K; Frater, J; Matthews, P; Payne, R; Addo, M; Gatanaga, H; Fujiwara, M; Hachiya, A; Koizumi, H; Kuse, N; 

Oka, S; Duda, A; Prendergast, A; Crawford, H; Leslie, A; Brumme, Z; Brumme, C; Allen, T; Brander, C; Kaslow, R; Tang, J; Hunter, E; 

Allen, S; Mulenga, J; Branch, S; Roach, T; John, M; Mallal, S; Ogwu, A; Shapiro, R; Prado, JG; Fidler, S; Weber, J; Pybus, OG; 

Klenerman, P; Ndung'u, T; Phillips, R; Heckerman, D; Harrigan, PR; Walker, BD; Takiguchi, M; Goulder, P 

Adaptation of HIV-1 to human leukocyte antigen class I 

NATURE 2009-APR 2; 458 (7238): 641-U108 

IF: 34,480 

Latorre, I; De Souza-Galvao, M; Ruiz-Manzano, J; Lacoma, A; Prat, C; Fuenzalida, L; Altet, N; Ausina, V; Dominguez, J 

Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults 

and children 

DIAGN MICR INFEC DIS 2009 NOV;65:236-246 

IF: 2,451 

López-Laso E, Ochoa-Sepúlveda JJ, Ochoa-Amor JJ, Bescansa-Heredero E, Camino-León R, Gascón-Jiménez FJ, Mateos-González 

ME, Pérez-Navero JL, Lao-Villadóniga JI, Ormazabal A, Artuch R, Beyer K. 

Segawa syndrome due to mutation Q89X in the GCH1 gene: a possible founder effect in Córdoba (southern Spain). 

J NEUROL 2009 Nov;256(11):1816-24. Epub 2009 Jun 16. 

IF: 2,903 

Mane, J; Loren, V; Pedrosa, E; Ojanguren, I; Xaus, J; Cabre, E; Domenech, E; Gassull, MA 

Lactobacillus fermentum CECT 5716 Prevents and Reverts Intestinal Damage on TNBS-induced Colitis in Mice 

INFLAMM BOWEL DIS 2009-AUG; 15 (8): 1155-1163 

IF: 4,643 

Mane, J; Pedrosa, E; Loren, V; Ojanguren, I; Fluvia, L; Cabre, E; Rogler, G; Gassull, MA 

Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis 

in Interleukin-10-Deficient Mice 


J NUTR 2009-MAR; 139 (3): 603-610 

IF: 4,091 

Marín-Gallén S, Clemente X, Planas R, Pujol I, Carrillo J, Carrascal J, Ampudia R, Pujol-Borrell R, Borràs FE, Vives-Pi M 

Prevention of experimental type 1 diabetes by immunotheraphy with syngeneic dendritic cells pulsed with antigenspecific 

apoptotic bodies 

J IMMUNOTHER 2009 

IF: 3,203 

Martínez-Hernández R, Soler-Botija C, Caselles L, Alias L, Also E, Bernal S, Baiget M, Tizzano EF. 

Analysis of the developmental pattern of human myotubes supports a prenatal delay of muscle maturation in spinal muscular 

atrophy. 

J NEUROPATH EXP NEUR 2009 May; 68(5):474-81 

IF: 4,564 

Massanella, M; Puigdomenech, I; Cabrera, C; Fernandez-Figueras, MT; Aucher, A; Gaibelet, G; Hudrisier, D; Garcia, E; Bofill, M; 

Clotet, B; Blanco, J 

Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells 

AIDS 2009-JAN 14; 23 (2): 183-188 

IF: 4,909 

Matilla-Dueñas A, Sánchez I, Corral-Juan M, Dávalos A, Alvarez R, Latorre P. 

Cellular and Molecular Pathways Triggering Neurodegeneration in the Spinocerebellar Ataxias. 

CEREBELLUM 2009 Nov 5. [Epub ahead of print] 

IF: 3,280 

Minuesa, G; Volk, C; Molina-Arcas, M; Gorboulev, V; Erkizia, I; Arndt, P; Clotet, B; Pastor-Anglada, M; Koepsell, H; Martinez- 

Picado, J 

Transport of Lamivudine [(-)-beta-L-2 ',3 '-Dideoxy-3 '-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse 

Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3 

J PHARMACOL EXP THER 2009-APR; 329 (1): 252-261 

IF: 4,093 

Miura, T; Brockman, MA; Schneidewind, A; Lobritz, M; Pereyra, F; Rathod, A; Block, BL; Brumme, ZL; Brumme, CJ; Baker, B; 

Rothchild, AC; Li, B; Trocha, A; Cutrell, E; Frahm, N; Brander, C; Toth, I; Arts, EJ; Allen, TM; Walker, BD 

HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced 

Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition 

J VIROL 2009; 83:2743-2755 

IF: 5,150 

Murphy, RL; Autran, B; Katlama, C; Brucker, G; Debre, P; Calvez, V; Clotet, B; Clumeck, N; Costagliola, D; Deeks, SG; Dorrell, L; 

Gatell, J; Haase, A; Klein, M; Lazzarin, A; Mcmichael, AJ; Papagno, L; Schacker, T; Wain-Hobson, S; Walker, BD; Youle, M 

A Step Ahead on the HIV Collaboratory 

SCIENCE 2009-juny-05; 324 (5932): 1264-1265 

IF: 29,747 

Paredes R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, Petropoulos CJ, Deeks SG, Kuritzkes DR. 

In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of 

lamivudine. 

J VIROL 2009 Feb;83(4):2038-43. Epub 2008 Nov 19 

IF: 5,150 

Parera, M; Perez-Alvarez, N; Clotet, B; Martinez, MA 

Epistasis among Deleterious Mutations in the HIV-1 Protease 

J MOL BIOL 2009-SEP 18; 392 (2): 243-250 

IF: 3,871 

Perez-Elias, MJ; Morellon, ML; Ortega, E; Hernandez-Quero, J; Rodriguez-Torres, M; Clotet, B; Felizarta, F; Gutierrez, F; Pineda, JA; 

Nichols, G; Lou, Y; Wire, MB 

Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic 

Impairment 

ANTIMICROB AGENTS CH 2009 DEC;53:5185-5196 


IF: 4,802 

Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD; EuroSIDA 

Study Group. 

Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic 

suppression. 

JAIDS-J ACQ IMM DEF 2009 Apr 15;50(5):457-63. 

IF: 4,207 

Prado, JG; Honeyborne, I; Brierley, I; Puertas, MC; Martinez-Picado, J; Goulder, PJR 

Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8(+) T-Cell Epitope in p1 Gag 

Protein 

J VIROL 2009-JAN 15; 83 (2): 1018-1025 

IF: 5,150 

Pruvost, A; Negredo, E; Theodoro, F; Puig, J; Levi, M; Ayen, R; Grassi, J; Clotet, B 

Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): 

Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir 

ANTIMICROB AGENTS CH 2009-MAY 1; 53 (5): 1937-1943 

IF: 4,802 

Puertas, MC; Buzon, MJ; Artese, A; Alcaro, S; Menendez-Arias, L; Perno, CF; Clotet, B; Ceccherini-Silberstein, F; Martinez- 

Picado, J 

Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication 

Capacity and Drug Susceptibility 

J VIROL 2009 AUG 1;83:7434-7439 

IF: 5,150 

Puigdomenech, I; Massanella, M; Cabrera, C; Clotet, B; Blanco, J 

On the steps of cell-to-cell HIV transmission between CD4 T cells 

RETROVIROLOGY 2009; 6:89 

IF: 4,105 

Radi M, Maga G, Alongi M, Angeli L, Samuele A, Zanoli S, Belluci L, Tafi A, Casaluce G, Giorgi G, Armand-Ugon M, 

Gonzalez E, Esté JA, Baltzinger M, Bec G, Dumas P, Ennifar E, Botta M 

Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (S-DABO) Derivatives as Potent HIV-1 Reverse 

Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants 

J MED CHEM 2009; 52, 840-851 

IF: 4,802 

Ramsay AJ, Quesada V, Sanchez M, Garabaya C, Sardà MP, Baiget M, Remacha A, Velasco G, López-Otín C. 

Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation 

mechanisms. 

HUM MOL GENET 2009 Oct 1;18(19):3673-83. Epub 2009 Jul 10. 

IF: 7,386 

Rousseau, CM; Lockhart, DW; Listgarten, J; Maley, SN; Kadie, C; Learn, GH; Nickle, DC; Heckerman, DE; Deng, W; 

Brander, C; Ndung'u, T; Coovadia, H; Goulder, PJR; Korber, BT; Walker, BD; Mullins, JI 

Rare HLA Drive Additional HIV Evolution Compared to More Frequent Alleles 

AIDS RES HUM RETROV 2009; 25:297-303 

IF: 2,178 

Rusconi S, Lo Cicero M, Viganò O, Sirianni F, Bulgheroni E, Ferramosca S, Bencini A, Bianchi A, Ruiz L, Cabrera C, Martinez-Picado J, 

Supuran CT, Galli M. 

New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses. 

Molecules 2009 May 22;14(5):1927-37 

IF: 2,359 

Russell, DG; Cardona, PJ; Kim, MJ; Allain, S; Altare, F 

Foamy macrophages and the progression of the human tuberculosis granuloma 

NAT IMMUNOL 2009; 10:943-948 

IF: 26,000 


Sabariegos R, Picazo F, Domingo B, Franco S, Martinez MA, Llopis J. 

Fluorescence resonance energy transfer-based assay for characterization of hepatitis C virus NS3-4A protease activity in live cells. 

ANTIMICROB AGENTS CH 2009 Feb;53(2):728-34. Epub 2008 Dec 8. 

IF: 4,802 

Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, Leitner T, Gaschen B, Theiler J, Paredes R, Su Z, Hughes MD, Gulick RM, 

Greaves W, Coakley E, Flexner C, Nusbaum C, Kuritzkes DR. 

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. 

PLOS ONE 2009 May 25;4(5):e5683. 

IF: 4,351 

Valles, X; Sarrias, MR; Casals, F; Farnos, M; Piner, R; Suarez, B; Morais, L; Mandomando, I; Sigauque, B; Roca, A; Alonso, PL; Torres, 

A; Thielens, NM; Lozano, F 

Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children 

TISSUE ANTIGENS 2009; 74:298-307 

IF: 2,330 

Vera, J; Fenutria, R; Canadas, O; Figueras, M; Mota, R; Sarrias, MR; Williams, DL; Casals, C; Yelamos, J; Lozano, F 

The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like 

syndrome 

P NATL ACAD SCI USA 2009; 106:1506-1511 

IF: 9,432 

Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R, on behalf of the NBI-6024 Study Group (Eva Aguilera). 

No effect of the altered peptide ligand NBI-6024 on β-cell residual function and insulin needs in new-onset type 1 diabetes. 

DIABETES CARE 2009, 32: 2036-2040 

IF: 6,718 

INVESTIGACIÓ CLÍNICA 

Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators. 

Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: 

retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). 

STROKE 2009 Jul;40(7):2442-9. Epub 2009 May 21. 

IF: 7,041 

Andres, A; Marcen, R; Valdes, F; Plumed, J; Sola, R; Errasti, P; Lauzurica, R; Pallardo, L; Bustamante, J; Amenabar, JJ; Plaza, JJ; 

Gomez, E; Grinyo, JM; Rengel, M; Puig, JM; Sanz, A; Asensio, C; Andres, I 

A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded 

criteria donors and at high risk of delayed graft function. 

CLIN TRANSPLANT 2009-JAN-FEB; 23 (1): 23-32 

IF: 2,004 

Antonio J. Blasco AJ, Ferrándiz C, García A, Lázaro P, Liso J 

Eficiencia de los agentes biológicos en el tratamiento de la psoriaris moderada-grave. 

Actas Dermosifiliogr 2009;100:792-803 (A) 

Arenillas JF, Sandoval P, Pérez de la Ossa N, Millán M, Guerrero C, Escudero D, Dorado L, López-Cancio E, Castillo J, Dávalos A. 

The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women 

than in men. 

STROKE 2009 ;40(2):344-349. Epub 2008 Dec 24 

IF: 7,041 

Bassas-Vila J 

Patrones histológicos de los procesos inflamatorios de la piel 

PIEL 2009;24:380-386 (A) 

Benvenuti F, Carrascosa JM, Boada A, Ferrandiz C. 

Disseminated Strongyloides stercoralis infection presenting with cutaneous manifestations in an immunosuppressed patient 

EUR J DERMATOL 200;19(4):404-5.(A) 


IF: 2,251 

Berenguer, J; Alvarez-Pellicer, J; Martin, PM; Lopez-Aldeguer, J; Von-Wichmann, MA; Quereda, C; Mallolas, J; Sanz, J; Tural, C; 

Bellon, JM; Gonzalez-Garcia, J 

Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients 

Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus 

HEPATOLOGY 2009-AUG; 50 (2): 407-413 

IF: 10,840 

Berenguer, J; Gonzalez-Garcia, J; Lopez-Aldeguer, J; Von-Wichmann, MA; Quereda, C; Hernando, A; Sanz, J; Tural, C; Ortega, E; 

Mallolas, J; Santos, I; Miralles, P; Montes, ML; Bellon, JM; Esteban, H 

Pegylated interferon alpha 2a plus ribavirin versus pegylated interferon alpha 2b plus ribavirin for the treatment of chronic 

hepatitis C in HIV-infected patients 

J ANTIMICROB CHEMOTH 2009-JUN; 63 (6): 1256-1263 

IF: 4,352 

Bielsa I. 

Nuevos anticuerpos en la dermatomiositis 

Actas Dermosifiliogr 2009;100;182-189 (R) 

Bielsa I. 

Dermatomiositis. 

DERMATOL CLIN 2009; doi: 10.1016 

IF: 1,294 

Bluhmki, E; Chamorro, A; Davalos, A; Machnig, T; Sauce, C; Wahlgren, N; Wardlaw, J; Hacke, W 

Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and 

subgroup analysis of a randomised controlled trial 

LANCET NEUROL 2009 DEC;8:1095-1102 

IF: 18,126 

Bonjoch A, Buzon MJ, Llibre JM, Negredo E, Puig J, Pérez-Alvarez N, Videla S, Martinez-Picado J, Clotet B. 

Transient Treatment Exclusively Containing Nucleoside Analogue Reverse Transcriptase Inhibitors in Highly Antiretroviral- 

Experienced Patients Preserves Viral Benefit When a Fully Active Therapy Was Initiated 

HIV CLIN TRIALS 2008 Nov-Dec;9(6):387-98. 

IF: 1,626 

Brea, D; Sobrino, T; Blanco, M; Fraga, M; Agulla, J; Rodriguez-Yanez, M; Rodriguez-Gonzalez, R; de la Ossa, NP; Leira, R; Forteza, J; 

Davalos, A; Castillo, J 

Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis 

confirmation 

ATHEROSCLEROSIS 2009-AUG; 205 (2): 561-567 

IF: 4,522 

Cabré E. 

Probióticos y prebióticos en la Enfermedad Inflamatoria Intestinal: Una revisión crítica 

Nutr Clin Med 2009; 3:31-39. 

Carrascosa JM 

Realidades, perspectivas e incertidumbres de la terapia UVB de banda estrecha en la psoriasis 

Actas Dermosifiliogr 2009; 100;3-6 (a) 

Carrascosa JM, Benvenuti F, Rodríguez C, Ferrándiz C 

Perfil de los pacientes con dermatosis en las manos remitidos a la unidad de contacto de un hospital terciario e impacto de las 

pruebas epicutáneas en el diagnóstico. 

Actas Dermosifiliogr 2009;100:445-55 (A) 

Carrascosa JM, F Vanaclocha. L Borrego. E Fernández-López. A Fuertes. L Rodríguez-Fernández-Freire. A Zulaica. A Tuneu.G 

Caballé. E Colomé. X Bordas. JM Hernanz. C Brufau. E Herrera. 

Revisión actualizada del tratamiento tópico de la psoriasis. 

Actas Dermosifiliogr 2009;100:190-200 


Carrascosa JM, Ferránidz C 

Tratamiento de la psoriasis: esperanzas y realidades en la era biológica 

PIEL 2009;24:61-63 (a) 

Carrion, S; Domenech, E; Romeu, J; Domenech, E 

Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab 

J CROHNS COLITIS 2009-SEP; 3 (3): 220-221 

IF: 1,729 

Casanova JM, Sanmartín V, Soria X, Ferrer M, Pujol RM, Ribera M 

Tratamiento tópico de la psoriasis (R) 

PIEL 2009;24:556-567 

Castroagudin, JF; Molina, E; Romero, R; Otero, E; Tome, S; Varo, E 

Improvement of Renal Function After the Switch from a Calcineurin Inhibitor to Everolimus in Liver Transplant Recipients with 

Chronic Renal Dysfunction 

LIVER TRANSPLANT 2009; 15:1792-1797 

IF: 3,724 

Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M; Working Group on Completion of 

Tuberculosis Treatment in Spain (Study ECUTTE). 

Tuberculosis treatment adherence and fatality in Spain. 

RESP RES Respir Res. 2009 Dec 1;10:121. 

IF: 3,127 

Coll R, Colomer M, Ragull S, Roldán J. 

Predictive factors for survival in idiopatic pulmonary fibrosis. 

MED CLIN-BARCELONA 2009 Dec 30. [Epub ahead of print] 

IF: 1,231 

Coll-Canti, J; Ramo, RA; Dorado, L; Guerrero, C; Serichol, M; Davalos, A; Martinez, EM 

Guillain-Barre syndrome and IVIg: does early initiation of treatment influence the mean hospital stay 

NEUROLOGIA 2009 MAY;24:217-219 

IF: 0,596 

Cybulla M, Walter KN, Schwarting A, Divito R, Feriozzi S, Sunder-Plassmann G; European FOS Investigators Group. (Pintos G) 

Kidney transplantation in patients with Fabry disease. 

TRANSPL INT 2009 Apr;22(4):475-81. Epub 2009 Jan 22. 

IF: 3,254 

de Mendoza C, Anta L, García F, Pérez-Elías MJ, Gutiérrez F, Llibre JM, Menéndez-Arias L, Dalmau D, Soriano V. 

HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines. 

AIDS REV 2009 Jan-Mar;11(1):39-51. 

IF: 3,786 

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. (Morera J). 

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified 

subgroup analysis of a randomised controlled trial. 

LANCET 2009 Oct 3;374(9696):1171-8. Epub 2009 Aug 27. 

IF: 30,758 

Descamps, A; Rousset, C; Millan, M; Spedding, M; Delagrange, P; Cespuglio, R 

Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleepwake 

cycle architecture 

PSYCHOPHARMACOLOGY 2009; 205:93-106 

IF: 4,103 

Doménech E. 

En contra de l’ús precoç de biològics en malaltia inflamatòria intestinal. 

ANN MED 2009; 92 (Supl 1): S1-S12. 

IF: 4,246 


Domenech, E; Manosa, M; Cabre, E 

Top-Down Therapy: Is the Evidence Strong Enough 

DIGEST DIS 2009;27(3):306-11. Epub 2009 Sep 24. 

IF: 1,487 

Dominguez J, Latorre I, Altet N, Mateo L, De Souza-Galvao M et al 

IFN-y_release assays to diagnose TB infection in the immunocompromised individual 

Expert Rev Respir Med 2009; 3 (3): 309-327 

Dominguez, A; Alvarez, J; Sabria, M; Carmona, G; Torner, N; Oviedo, M; Cayla, J; Minguell, S; Barrabeig, I; Sala, M; Godoy, R; 

Camps, N 

Factors influencing the case-fatality rate of Legionnaires' disease 

INT J TUBERC LUNG D 2009-MAR; 13 (3): 407-412 

IF: 2,548 

Dorado L, Millán M, Pérez de la Ossa N, Guerrero C, Gomis M, López-Cancio E, Ricciardi AC, Dávalos A. 

Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous 

thrombolysis. 

EUR J NEUROL 2009 Nov 12. [Epub ahead of print] 

IF: 2,510 

Dorado, L; Arenillas, JF; Millan, M; De La Ossa, NP; Guerrero, C; Davalos, A 

Prognostic impact of time-point and degree of arterial recanalization of acute middle cerebral artery occlusions after intravenous 

tPA administration 

MED CLIN-BARCELONA 2009-MAY 2; 132 (16): 609-615 

IF: 1,231 

Escudero D, E. López-Cancio, A. Olivé, E. Martínez-Cáceres, J. Capellades. 

Vasculopatía cerebral fulminante en el Síndrome de Sjögren. 

NEUROLOGIA 2009; 24(7); 498-510 

IF: 0,596 

Esteban-Oliva, D; Pintos-Morell, G; Konrad, M 

Long-term follow-up of a patient with primary hypomagnesaemia and secondary hypocalcaemia due to a novel TRPM6 mutation 

EUR J PEDIATR 2009-APR; 168 (4): 439-442 

IF: 1,634 

Ferrándiz C, Carrascosa JM 

Tratamiento tópico vs sistémico en la psoriasis. ¿Dilema o acuerdo 

PIEL 2009;24:227-229 (a) 

Fuentes, B; Castillo, J; Jose, BS; Leira, R; Serena, J; Vivancos, J; Davalos, A; Nunez, AG; Egido, J; Diez-Tejedor, E 

The Prognostic Value of Capillary Glucose Levels in Acute Stroke The GLycemia in Acute Stroke (GLIAS) Study 

STROKE 2009-FEB; 40 (2): 562-568 

IF: 7,041 

Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, Negredo E, Pérez-Alvarez N, Tarrats A, Clotet B. 

Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders. 

AIDS PATIENT CARE ST 2009 Jun;23(6):463-8. 

IF: 2,683 

Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, 

Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí AG, Antó JM; Phenotype and Course of COPD Study Group. 

Physical activity and clinical and functional status in COPD. 

CHEST 2009 Jul;136(1):62-70. Epub 2009 Mar 2. 

IF: 6,360 

Garcia-Aymerich, J; Agusti, A; Barbera, JA; Belda, J; Farrero, E; Ferrer, A; Ferrer, J; Galdiz, JB; Gea, J; Gomez, FP; Monso, E; 

Morera, J; Roca, J; Sauleda, J; Anto, JM 

Phenotypic Heterogeneity of Chronic Obstructive Pulmonary Disease 

ARCH BRONCONEUMOL 2009-MAR; 45 (3): 129-138 

IF: 2,166 


García-Casares E, Mateo L, García-Melchor E, Mínguez S, Vall-Llobera F, Cañellas J, Holgado S. 

Síndrome sarcoidosis-linfoma. 

Reumatología Clínica 2009; 5 (1): 31-33. 

García-Molina A, Enseñat-Cantallops A, Sánchez-Carrión R, Roig-Rovira T. 

Assessment of decision-making capacity in primary and secondary progressive multiple sclerosis. 

NEUROLOGIA 2009 Mar;24(2):94-7. 

IF: 0,596 

Gasser, O; Bihl, F; Sanghavi, S; Rinaldo, C; Rowe, D; Hess, C; Stablein, D; Roland, M; Stock, P; Brander, C 

Treatment-dependent Loss of Polyfunctional CD8+T-cell Responses in HIV-infected Kidney Transplant Recipients Is 

Associated with Herpesvirus Reactivation 

AM J TRANSPLANT 2009-APR; 9 (4): 794-803 

IF: 6,433 

Gomez, J; Modol, J; Garcia-Nunez, M; Banos, V; Lorenzo, M; Pedro-Botet, ML; Hernandez, T; Herrero, JA; Ruiz, J; Sabria,M 

Low mortality rate in an outbreak of Legionnaires' disease: Correlation with the cytopathogenity study 

MED CLIN-BARCELONA 2009; 133:325-329 

IF: 1,231 

Gomis M, Ois A, Rodríguez-Campello A, Cuadrado-Godia E, Jiménez-Conde J, Subirana I, Dávalos A, Roquer J. 

Outcome of intracerebral haemorrhage patients pre-treated with statins. 

EUR J NEUROL 2009 Nov 12. [Epub ahead of print] 

IF: 2,510 

Gomis, M; Sobrino, T; Ois, A; Millan, M; Rodriguez-Campello, A; de la Ossa, NP; Rodriguez-Gonzalez, R; Jimenez-Conde, J; 

Cuadrado-Godia, E; Roquer, J; Davalos, A 

Plasma beta-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype 

STROKE 2009-OCT; 40 (10): 3197-3201 

IF: 7,041 

Gonzalez N, Xicoy B, Olivé A,Jové J, Ribera JM, Feliu E 

Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx 

Ear Nose Throat J 2009;ID: 19688705 

Grados-Canovas D; Balo S; Benitez-Diaz R; Romeu J 

Meningitis simultaneously due to Cryptococcus neoformans and Mycobacterium tuberculosis in a patient with HIV infection 

MED CLIN-BARCELONA 2009-SEP 12; 133 (9): 361-362 

IF: 1,231 

Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, 

Schneider D, Schwamm LH, Leal JS, Söhngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S. 

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or 

perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. 

LANCET NEUROL 2009 Feb;8(2):141-50. Epub 2008 Dec 25 

IF: 18,126 

Heras, E; Llibre, JM; Sirera, G; Mate, JL; Boix, V; Rey-Joly, C; Clotet, B 

Lymphogranuloma Venerium Proctitis in the Setting of HIV: A Case Report and Differential Diagnosis 

AIDS PATIENT CARE ST 2009-JUL; 23 (7): 493-494 

IF: 2,683 

Horne R, Kovacs C, Katlama C, Clotet B, Fumaz CR, Youle M, Kulasegaram R, Fisher M, Cohen C, Slim J, Shalit P, Cooper V, Tsoukas 

C. 

Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives 

AIDS RES THER 2009 Feb 5;6:2. 

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, 

Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, 

Wentworth D. 

Interleukin-2 therapy in patients with HIV infection. 


NEW ENGL J MED 2009 Oct 15;361(16):1548-59. 

IF: 47,050 

Katlama C, Haubrich R, Lalezari J, Lazzarin A, Madruga JV, Molina JM, Schechter M, Peeters M, Picchio G, Vingerhoets J, Woodfall 

B, De Smedt G; DUET-1, DUET-2 study groups. 

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled 

trials. 

AIDS 2009 Nov 13;23(17):2289-300 

IF: 4,909 

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine 

Toxicity Multicohort Collaboration. 

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. 

AIDS 2009 Aug 24;23(13):1689-99 

IF: 4,909 

Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomassen L, Wahlgren N; SITS investigators. 

Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical 

course and prognostic significance. 

J NEUROL NEUROSUR PS 2009 Mar;80(3):273-8. Epub 2008 Oct 17. 

IF: 4,869 

Lacoma A., Prat C., Andreo F., Dominguez J. 

Biomarkers in the management of COPD. 

EUR RESPIR J 2009; 18: 96-104 

IF: 5,527 

Laguno, M; Cifuentes, C; Murillas, J; Veloso, S; Larrousse, M; Payeras, A; Bonet, L; Vidal, F; Milinkovic, A; Bassa, A; Villalonga, C; 

Perez, I; Tural, C; Martinez-Rebollar, M; Calvo, M; Blanco, JL; Martinez, E; Sanchez-Tapias, JM; Gatell, JM; Mallolas, J 

Randomized Trial Comparing Pegylated Interferon alpha-2b Versus Pegylated Interferon alpha-2a, Both Plus Ribavirin, to Treat 

Chronic Hepatitis C in Human Immunodeficiency Virus Patients 

HEPATOLOGY 2009-JAN; 49 (1): 22-31 

IF: 10,840 

Leal L, Carrascosa JM, Boada A, Ferrándiz C. 

Mucous membrane ulcers in an immunocompromised patient. Cutaneous cytomegalovirus infection. 

ARCH DERMATOL 2009;145:931-6. 

IF: 4,760 

Leira, R; Millan, M; Diez-Tejedor, E; Blanco, M; Serena, J; Fuentes, B; Rodriguez-Yanez, M; Castellanos, M; Lago, A; Davalos, A; 

Castillo, J 

Age determines the prognosis of the modifications of the arterial blood pressure Turing the acute phase of ischemic stroke (TICA 

study). 

HYPERTENSION 2009; 54:769-774 

IF: 6,614 

Llibre, JM 

First-Line Boosted Protease Inhibitor-Based Regimens in Treatment-Naive HIV-1-Infected Patients - Making a Good Thing Better 

AIDS REV 2009 OCT-DEC;11:215-222 

IF: 3,786 

Llibre, JM; Falco, V; Tural, C; Negredo, E; Pineda, JA; Munoz, J; Ortega, E; Videla, S; Sirera, G; Martinez, E; Miralles, C; 

Iribarren, J; Galindo, MJ; Domingo, P; d'Arminio-Monforte, A; Miro, JM; Clotet, B 

The Changing Face of HIV/AIDS in Treated Patients 

CURR HIV RES 2009-JUL; 7 (4): 365-377 

IF: 1,978 

Loscos J, Tapia G, de la Cámara J. 

Queratoconjuntivitis límbica superior (Sd. Theodore): estudio clinicopatológico. 

ANN OPHTHALMOL 2009;17(3):158-161. 

IF: 0,157 


M Batlle, Quesada MD, Moreno M, JM Ribera. 

Brote de infección por Blastoschizomyces spp en una unidad de hematologia. Estúdio de 6 casos y hallazgo de la fuente de 

infección 

MED CLIN-BARCELONA 2009; 10 JUNIO 

IF: 1,231 

Mack, U; Migliori, GB; Sester, M; Rieder, HL; Ehlers, S; Goletti, D; Bossink, A; Magdorf, K; Holscher, C; Kampmann, B; Arend, SM; 

Detjen, A; Bothamley, G; Zellweger, JP; Milburn, H; Diel, R; Ravn, P; Cobelens, F; Cardona, PJ; Kan, B; Solovic, I; Duarte, R; Cirillo, 

DM; Lange, C 

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis A TBNET consensus statement 

EUR RESPIR J 2009; 33:956-973 

IF: 5,527 

Mallolas, J; Podzamczer, D; Milinkovic, A; Domingo, P; Clotet, B; Ribera, E; Gutierrez, F; Knobel, H; Cosin, J; Ferrer, E; Arranz, JA; 

Roca, V; Vidal, F; Murillas, J; Pich, J; Pedrol, E; Llibre, JM; Dalmau, D; Garcia, I; Aranda, M; Cruceta, A; Martinez, E; Blanco, JL; de 

Lazzari, E; Gatell, JM 

Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving 

a LPV/r-Containing HAART: The ATAZIP Study 

JAIDS-J ACQ IMM DEF 2009; 51:29-36 

IF: 4,207 

Mañosa M, López San Román A, Garcia-Planella E, Bastida G, Hinojosa J, Gonzalez-Lama Y, Masnou H, Domènech E. 

Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis. 

DIGESTION 2009;80(1):30-5. Epub 2009 May 14. 

IF: 1,770 

Marin, I; Serra, I; Manosa, M; Cabre, E; Domenech, E 

Psoas abscess as a complication of Crohn's disease: report of three cases and literature review 

Gastroenterol Hepatol 2009 Oct;32(8):557-61. Epub 2009 Jun 17. 

Martínez E, Arranz JA, Podzamczer D, Loncá M, Sanz J, Barragán P, Ribera E, Knobel H, Roca V, Gutiérrez F, Blanco JL, Mallolas J, 

Llibre JM, Clotet B, Dalmau D, Segura F, Arribas JR, Cosín J, Barrufet P, Casas E, Ferrer E, Curran A, González A, Pich J, Cruceta A, 

Arnaiz JA, Miró JM, Gatell JM; BICOMBO Study Team. 

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or 

tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. 

JAIDS-J ACQ IMM DEF 2009 Jul 1;51(3):290-297 

IF: 4,207 

Michetti, P; Stelle, M; Juillerat, P; Gassull, M; Heil, FJ; Stange, E; Mottet, C; Gonvers, JJ; Pittet, V; Vader, JP; Froehlich, F; Felley, C 

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II 

J CROHNS COLITIS 2009; 3:232-240 

IF: 1,729 

Miravitlles, M; Marin, A; Monso, E; Vila, S; de la Roza, C; Hervas, R; Esquinas, C; Garcia, M; Millares, L; Morera, J; Torres,A 

Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD 

EUR RESPIR J 2009 NOV;34:1066-1071 

IF: 5,527 

Moltó A, Olivé A 

Anti-IL-1 molecules: New comers and new indications 

JOINT BONE SPINE 2009 Dec 30. PMID: 20045371 

IF: 2,250 

Molto, J; Llibre, JM; Ribera, E; Minguez, C; del Rio, JS; Pedrol, E; Vallecillo, G; Cedeno, S; Valle, M; Miranda, C; Negredo, E; Clotet, 

B 

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis. 

J ANTIMICROB CHEMOTH 2009-MAY; 63 (5): 992-997 

IF: 4,352 

Morales-Indiano C, Lauzurica R, Pastor MC, Bayés B, Sancho A, Troya M, Romero R. 


Greater posttransplant inflammation and oxidation are associated with worsening kidney function in patients with pretransplant 

diabetes mellitus. 

TRANSPL P 2009 Jul-Aug;41(6):2126-8. 

IF: 0,994 

Moreno, S; Miralles, C; Negredo, E; Domingo, P; Estrada, V; Gutierrez, F; Lozano, F; Martinez, E 

Disorders of Body Fat Distribution in HIV-1-Infected Patients 

AIDS REV 2009-JUL-SEP; 11 (3): 126-134 

IF: 3,786 

Munoz-Moreno, JA; Fumaz, CR; Ferrer, MJ; Gonzalez-Garcia, M; Molto, J; Negredo, E; Clotet, B 

Neuropsychiatric Symptoms Associated with Efavirenz: Prevalence, Correlates, and Management. A Neurobehavioral Review 

AIDS REV 2009-APR-JUN; 11 (2): 103-109 

IF: 3,786 

N Gonzalez, B Xicoy, A Olivé, J Jové, JM Ribera. 

Systemic lupus eritematosus in a patient with primary MALT lymphoma of the larinx. 

Ear Nose Throat J 2009; 88: E4-E5. 

Navarro-Llavat, M; Domenech, E; Bernal, I; Sanchez-Delgado, J; Manterola, JM; Garcia-Planella, E; Manosa, M; Cabre, E; Gassull, 

MA 

Prospective, Observational, Cross-Sectional Study of Intestinal Infections among Acutely Active Inflammatory Bowel Disease 

Patients 

DIGESTION 2009;80(1):25-9. Epub 2009 May 14. 

IF: 1,770 

Nos P; Domenech E 

Apheresis in inflammatory bowel disease 

Gastroenterol Hepatol 2009 Aug-Sep;32(7):509-18. Epub 2009 Jul 15. 

Optimising the Analysis of Stroke Trials (OAST) Collaboration, Gray LJ, Bath PM, Collier T. 

Should stroke trials adjust functional outcome for baseline prognostic factors 

STROKE 2009 Mar;40(3):888-94. Epub 2009 Jan 22. 

IF: 7,041 

Ostrowski, M; Lauzurica, R; Morales, J; van Hooff, J 

Renal function and safety are well-maintained after conversion from twice-daily prograf (r) to once-daily advagraf (r) in stable 

kidney transplant patients: A phase III study. 

TRANSPL INT 2009-AUG; 22: 196-196 

IF: 3,254 

Pauls, E; Ballana, E; Moncunill, G; Bofill, M; Clotet, B; Ramo-Tello, C; Este, JA 

Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4 

AIDS 2009-JAN 14; 23 (2): 266-268 

IF: 4,909 

Pedro-Botet ML, Yu VL. 

Treatment strategies for Legionella infection. 

EXPERT OPIN PHARMACO 2009 May;10(7):1109-21. 

IF: 2,018 

Pérez de la Ossa, N; Millan, M; Arenillas, JF; Sanchez-Ojanguren, J; Palomeras, E; Dorado, L; Guerrero, C; Davalos, A 

Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous 

thrombolysis 

J NEUROL 2009 AUG;256:1270-1276 

IF: 2,903 

Pérez-Elias MJ, Sánchez-Conde M, Soriano V, Mallolas J, Luque I, Rodríguez-Alcántara F; Fosamprenavir Expanded Access Program 

Group. 

Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access 

Program. 


ENFERM INFEC MICR CL 2009 Jan;27(1):28-32. Epub 2009 Jan 9. 

IF: 1,393 

Perez-Elias, MJ; Gatell, JM; Flores, J; Santos, J; Vera-Medez, F; Clotet, B; Moreno, A; Perez-Molina, JA; Vendrell, B; Serrano, O 

Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatment-Experienced HIV Patients 

HIV CLIN TRIALS 2009-JUL-AUG; 10 (4): 269-275 

IF: 1,626 

Podzamczer, D; Ferrer, E; Martinez, E; del Rio, L; Rosales, J; Curto, J; Ribera, E; Barrufet, P; Llibre, JM; Aranda, M 

How Much Fat Loss Is Needed for Lipoatrophy to Become Clinically Evident 

AIDS RES HUM RETROV 2009-JUN; 25 (6): 563-567 

IF: 2,178 

Podzamczer, D; Soriano, V; Andrade-Villanueva, J, Clotet B, Taylor S, Rockstroh J, Domingo P, Reiss P, Gellermann HJ, Cairns V, de 

Rossi L. 

Comparison of lipid profile with nevirapine versus atazanavir/ritonavir, both combined with tenofovir DF and emtricitabine 

(TDF/FTC), in treatmentnaive HIV-1-infected patients: ARTEN study week 48 results. 

ANTIVIR THER 2009; 7: A51-A51 

IF: 4,322 

Porrini, E; Bayes, B; Diaz, JM; Ibernon, M; Benitez, R; Dominguez, R; Moreno, JM; Delgado, P; Lauzurica, R; Silva, I; Moreso, F; 

Lampreabe, I; Arias, M; Osuna, A; Torres, A 

Hyperinsulinemia and Hyperfiltration in Renal Transplantation 

TRANSPLANTATION 2009-JAN 27; 87 (2): 274-279 

IF: 3,498 

Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote 

EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study 

Group. 

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. 

GASTROENTEROLOGY 2009 May;136(5):1618-28.e2. Epub 2009 Jan 22. 

IF: 12,899 

Puig ll, Carrascosa JM, Daudén E, Sánchez Carazo JL, Ferrándiz C, Sanchez-Regaña M et al. 

Documento de consenso sobre evaluación y tratamiento de la psoriasis moderada/grave del Grupo de Psoriasis de la 

Academia Española de Dermatología y Venereología 

Actas Dermosifiliogr 2009;100:277-86 (a) 

Puig ll, Carrascosa JM, Daudén E, Sánchez Carazo JL, Ferrándiz C, Sanchez-Regaña M et al. 

Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos 

Actas Dermosifiliogr 2009;100:386-413 (a) 

Pulido, F; Perez-Valero, I; Delgado, R; Arranz, A; Pasquau, J; Portilla, J; Rubio, R; Gonzalez-Garcia, J; Miralles, P; Perez-Elias, MJ; 

Ocampo, A; Hernando, A; Estrada, V; Clotet, B; Podzamczer, D; Arribas, JR 

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV 

suppression 

ANTIVIR THER 2009; 14 (2): 195-201 

IF: 4,322 

Rahier, JF; Ben-Horin, S; Chowers, Y; Conlon, C; De Munter, P; D'Haens, G; Domenech, E; Eliakim, R; Eser, A; Frater, J; Gassull, M; 

Giladi, M; Kaser, A; Lemann, M; Moreels, T; Moschen, A; Pollok, R; Reinisch, W; Schunter, M; Stange, EF; Tilg, H; Van Assche, G; 

Viget, N; Vucelic, B; Walsh, A; Weiss, G; Yazdanpanah, Y; Zabana, Y; Travis, SPL; Colombel, JF 

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory 

bowel disease 

J CROHNS COLITIS 2009-JUN; 3 (2): 47-91 

IF: 1,729 

Rodriguez-Arrondo, F; Aguirrebengoa, K; Portu, J; Munoz, J; Garcia, MA; Goikoetxea, J; Martinez, E; Iribarren, JA; Perez-Alvarez, N; 

Negredo, E; Clotet, B 

Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine 

CURR HIV RES 2009 SEP;7:526-532 

IF: 1,978 


Rodriguez-Yanez, M; Alvarez-Sabin, J; Davalos, A; Diez-Tejedor, E; Castillo, J 

Thrombolytic therapy for acute ischemic stroke. Experience of SITS (Safe Implementation of Thrombolysis in Stroke) register 

NEUROLOGIA 2009; 24:288-291 

IF: 0,596 

Rodríguez-Yáñez M, Sobrino T, Blanco M, de la Ossa NP, Brea D, Rodríguez-González R, Leira R, Dávalos A, Castillo J. 

High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke. 

DIS MARKERS 2009;26(4):189-95 

IF: 2,026 

Romero-Gómez M, Diago M, Andrade RJ, Calleja JL, Salmerón J, Fernández-Rodríguez CM, Solà R, García-Samaniego J, Herrerías 

JM, De la Mata M, Moreno-Otero R, Nuñez O, Olveira A, Durán S, Planas R; Spanish Treatment of Resistance to Insulin in Hepatitis 

C Genotype 1 Group. 

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a 

plus ribavirin. 

HEPATOLOGY 2009 Dec;50(6):1702-8. 

IF: 10,840 

Roset-Llobell, J; García-Elías, M; Montero, J; Valls-Solé, J; Pascual-Leone, A. 

Syndrome, Can It Cause Focal Dystonia 

MOVEMENT DISORD 2009; Vol. 24, No. 11 

IF: 4,014 

Ruiz-Manzano J., Prat C., García-Oliver I., Domínguez J. 

Diagnosis and treatment of pneumococcal pneumonia. 

J INFECT DIS 2009; 3: 86-89 

IF: 5,865 

Saag M, Goodrich J, Fätkenheuer G, Clotet B, Clumeck N, Sullivan J, Westby M, van der Ryst E, Mayer H; A4001029 Study Group. 

A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1. 

J INFECT DIS 2009 Jun 1;199(11):1638-47. 

IF: 5,865 

Sala M, Morillas RM, Planas R. 

Virus de la hepatitis C y carcinoma hepatocelular. 

Hepatitis Hoy 2009;5:15-23 

Sanclemente C., Suárez C., Escudero D., Piedecausa M., Romero J.M., Ceballos A., Gadelha T., Monreal M and the FRENA 

Investigators. 

Gender and Outcome in Patients with Coronary Cerebrovascular or Peripheral Artery Disease. Findings from the FRENA Registry. 

The Open Atherosclerosis & Thrombosis Journal 2009; 2: 45-50 

Sancho A, Pastor MC, Troya M, Bonal J, Bayés B, Morales-Indiano C, Lauzurica R, Romero R. 

Hepcidin and iron deficiency in pre-kidney transplant patients. 

TRANSPL P Jul-Aug;41(6):2079-81. 

IF: 0,994 

Santin, S; Ars, E; Rossetti, S; Salido, E; Silva, I; Garcia-Maset, R; Gimenez, I; Ruiz, P; Mendizabal, S; Nieto, JL; Pena, A; Camacho, JA; 

Fraga, G; Cobo, MA; Bernis, C; Ortiz, A; de Pablos, AL; Sanchez-Moreno, A; Pintos, G; Mirapeix, E; Fernandez-Llama, P; Ballarin, J; 

Torra, RFSGS Study Grp 

TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis 

NEPHROL DIAL TRANSPL 2009 OCT;24:3089-3096 

IF: 3,306 

Santos, JR; Molto, J; Llibre, JM; Perez, N; Capitan, MC; Miranda, C; Clotet, B 

Unboosted Atazanavir Plus Co-formulated Lamivudine/Abacavir as a Ritonavir-Sparing Simplification Strategy in Routine 

Clinical Practice 

HIV CLIN TRIALS 2009-MAY-JUN; 10 (3): 129-134 

IF: 1,626 

Schusselé Filliettaz S, Juillerat P, Burnand B, Arditi C, Windsor A, Beglinger C, Dubois RW, Peytremann-Bridevaux I, Pittet V, 


Gonvers JJ, Froehlich F, Vader JP; EPAGE II Study Group. 

Appropriateness of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease. 

ENDOSCOPY 2009 Mar;41(3):218-26. Epub 2009 Mar 11. 

IF: 5,545 

Serra A, Romero R r 

La obesidad como causa de enfermedad renal 

REV ESP OBESIDAD 2009. Vol 7 núm 4. Julio-Agosto: 192-199 

Soler-Cataluna, JJ; Calle, M; Cosio, BG; Marin, JM; Monso, E; Alfageme, I 

Welfare quality standards in the EPOC 

ARCH BRONCONEUMOL 2009-JUL; 45 (7): 361-362 IF: 2,166 

Soler-Cataluna, JJ; Calle, M; Cosio, BG; Marin, JM; Monso, E; Alfageme, I 

Health-Care Quality Standards in Chronic Obstructive Pulmonary Disease 

ARCH BRONCONEUMOL 2009-APR; 45 (4): 196-203 

IF: 2,166 

Sterry W, Bagot M, Ferrandiz C, Kragballe K, Papp K, Stingl G. 

Immunosuppressive therapy in dermatology and PML. 

J DTSCH DERMATOL GES 2009 Jan;7(1):5. (a) 

IF: 1,403 

Teal P, Davis S, Hacke W, Kaste M, Lyden PD; Modified Randomized Exposure Controlled Trial Study Investigators, Fierus M; Bayer 

HealthCare AG. 

A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and 

pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic 

stroke: modified Randomized Exposure Controlled Trial (mRECT). 

STROKE 2009 Nov;40(11):3518-25. Epub 2009 Sep 10. 

IF: 7,041 

Thijs, VNS; Peeters, A; Vosko, M; Aichner, F; Schellinger, PD; Schneider, D; Neumann-Haefelin, T; Rother, J; Davalos, A; Wahlgren, 

N; Verhamme, P 

Randomized, Placebo-Controlled, Dose-Ranging Clinical Trial of Intravenous Microplasmin in Patients With Acute Ischemic Stroke 

STROKE 2009; 40:3789-3795 

IF: 7,041 

Toro C, Soriano V; Grupo Español de Estudio del VIH-2 y HTLV-1/2. 

Human immunodeficiency virus type 2 and human T-cell lymphotropic virus type 1 and type 2 infections in Spain: an update. 

ENFERM INFEC MICR CL 2009 Aug-Sep;27(7):377-9. Epub 2009 Apr 9. 

IF: 1,393 

Tsibris, AMN; Paredes, R; Chadburn, A; Su, ZH; Henrich, TJ; Krambrink, A; Hughes, MD; Aberg, JA; Currier, JS; Tashima, K; Godfrey, 

C; Greaves, W; Flexner, C; Skolnik, PR; Wilkin, TJ; Gulick, RM; Kuritzkes, DR 

Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group 

A5211 

CLIN INFECT DIS 2009 març-01;48:642-649 

IF: 8,195 

Vick-Fragoso R, Hernández-Oliva G, Cruz-Alcázar J, Amábile-Cuevas CF, Arvis P, Reimnitz P, Bogner JR; STIC Study Group. 

Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin 

and skin structure infections. 

INFECTION 2009 Oct;37(5):407-17. 

IF: 2,051 

Vilas, D; de la Ossa, NP; Millan, M; Capellades, J; Davalos, A 

Brainstem lesions in diffusion sequences of baseline MRI can be reversible after arterial recanalization. 

NEUROLOGY 2009-SEP 8; 73 (10): 813-815 

IF: 8,172 

Yeni P, Lamarca A, Berger D, Cimoch P, Lazzarin A, Salvato P, Smaill FM, Teofilo E, Madison SJ, Nichols WG, Adkison KK, Bonny T, 


Millard J, McCarty D; EPIC (CCR100136) study team. 

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve 

patients: results of the EPIC study (CCR100136). 

HIV MED 2009 Feb;10(2):116-24 

IF: 2,878 

Zabana Y, Barreiro M, Mañosa M, Lorenzo A, Cabré E, Domènech E 

Cervical dysplasia in immunosupressed IBD women 

INFLAMM BOWEL DIS 2009 Jan 14. Epub ahead of print 

IF: 4,643 

INVESTIGACIÓ TRASLACIONAL 

Brumme Z, Wang B, Nair K, Brumme C, de Pierres C, Reddy S, Julg B, Moodley E, Thobakgale C, Lu Z, van der Stok M, Bishop K, 

Mncube Z, Chonco F, Yuki Y, Frahm N, Brander C, Carrington M, Freedberg K, Kiepiela P, Goulder P, Walker B, Ndung'u T, Losina E. 

Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C 

infection: results from Sinikithemba Cohort, Durban, South Africa. 

CLIN INFECT DIS 2009 Sep 15;49(6):956-964 

IF: 8,195 

Cardona, PJ 

A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection 

INFECTION 2009; 37:80-86 

IF: 2,051 

Colobran R, Casamitjana N, Roman A, Faner R, Pedrosa E, Arostegui JI, Pujol-Borrell R, Juan M, Palou E. 

Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation. 

GENES IMMUN 2009 Apr;10(3):254-9. Epub 2009 Jan 15. 

IF: 4,222 

Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; 

EuroSIDA Study Group. 

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing 

zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. 

J INFECT DIS 2009 Sep 1;200(5):687-97. 

IF: 5,865 

Cuenca-Leon, E; Banchs, I; Serra, SA; Latorre, P; Fernandez-Castillo, N; Corominas, R; Valverde, MA; Volpini, V; Fernandez- 

Fernandez, JM; Macaya, A; Cormand, B 

Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene 

J NEUROL SCI 2009-MAY 15; 280 (2): 10-14 

IF: 2,324 

Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A, 

De Luca A, Easterbrook P, Günthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM, 

Martinson JJ, Detels R, Margolick JB, Jacobson LP, Descombes P, Antonarakis SE, Beckmann JS, O'Brien SJ, Letvin NL, McMichael 

AJ, Haynes BF, Carrington M, Feng S, Telenti A, Goldstein DB; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). 

Common genetic variation and the control of HIV-1 in humans. 

PLOS GENET 2009 Dec;5(12):e1000791. Epub 2009 Dec 24. 

IF: 9,532 

Fumaz CR, Gonzalez-Garcia M, Borras X, Ferrer MJ, Muñoz-Moreno JA, Peña R, Perez-Alvarez N, Puig J, Paredes R, Fernandez- 

Castro J, Clotet B. 

Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high 

psychological stress. 

JAIDS-J ACQ IMM DEF 2009 Nov 1;52(3):427-8. 

IF: 4,207 

Garrabou, G; Moren, C; Gallego-Escuredo, JM; Milinkovic, A; Villarroya, F; Negredo, E; Giralt, M; Vidal, F; Pedrol, E; Martinez, E; 

Cardellach, F; Gatell, JM; Miro, O 

Genetic and Functional Mitochondrial Assessment of HIV-Infected Patients Developing HAART-Related Hyperlactatemia 


JAIDS-J ACQ IMM DEF 2009 DEC 1;52:443-451 

IF: 4,207 

Gassull, MA 

Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease 

NAT CLIN PRACT GASTR 2009-FEB; 6 (2): 80-81 

IF: 4,502 

Grifols, JR; Serrano, A; Ester, A; Junca, J; Muniz, E 

Vital transfusion in patients with multiple antibodies against common erythrocyte antigens 

TRANSFUS APHER SCI 2009-APR; 40 (2): 105-107 

IF: 0,938 

Harris, M; Cote, H; Ochoa, C; Allavena, C; Negredo, E; Thorne, A; Cahn, P; Zala, C; Raffi, F; Clotet, B; Singer, J; Montaner, J 

A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral- 

Naive HIV-Infected Patients 

JAIDS-J ACQ IMM DEF 2009-març-01; 50 (3): 335-337 

IF: 4,207 

Ibarrondo, J; Brander, C 

Profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage and antigen exposure 

FUTURE VIROL 2009; 4:325-328 

IF: 0,713 

Ibernon, M; Moreso, F; Moreno, JM; Bestard, O; Cruzado, JM; Grinyo, JM; Ricart, W; Fernandez-Real, JM; Seron, D 

Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After Renal Transplantation 

TRANSPLANTATION 2009-jul-27; 88 (2): 272-278 

IF: 3,498 

Lederman MM, Este J. 

Targeting a host element as a strategy to block HIV replication: is it nice to fool with Mother Nature 

Curr Opin HIV AIDS 2009 Mar;4(2):79-81. 

Loggi E, Bihl F, Chisholm JV, Biselli M, Bontadini A, Vitale G, Ercolani G, Grazi GL, D’Pinna A, Bernardi M, Brander C, Andreone, P 

Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft. 

J HEPATOL 2009; 50:625-630 

IF: 7,818 

López-Hoyos M, Pascual-Salcedo D, Mozo L, Juliá MR, Rodríguez-Mahou M, Almeida D, Alsina M, Vargas ML, Sequí J, Sáez R, 

Rodrigo MJ, Carrasco A, Palomino P, Bas J, Plaza A, Barrios Y, Prada A, Castro R, Pastor RM, Marcos J, Fernández-Pereira L, 

Sánchez-Ibarrola A, Rodríguez C, Nocito M, Amengual MJ, Alarcón I, Figueredo MA, Jaímez L, Jimenez J, Serrano A, Ocaña E, 

Martínez-Cáceres E, Santamaría M, Villegas N 

Large evaluation of anti-cardiolipin and anti-b2 glycoprotein I assays: results from the Autoimmunity workshop of the Spanish 

society of Immunology 

Inmunología 2009; Vol. 28 / Núm 2/ Abril-Junio 2009: 74-78 

Lucena, MI; Martinez, C; Ulzurrun, E; Garcia-Martin, E; Pelaez, G; Romero-Gomez, M; Castiella, A; Planas, R; Guarner, C; Salmeron, 

JF; Borraz, Y; Andrade, RJ; Agundez, JA 

Manganese superoxide dismutase functional polymorphism (sod2 v16a) is a major determinant of idiosyncratic drug-induced liver 

injury 

BASIC CLIN PHARMACOL 2009-AUG; 105: 77-77 

IF: 2,308 

Marin-Gallen S, Clemente-Casares X, Planas R, Pujol-Autonell I, Carrascal J, Carrillo J, Ampudia R, Verdaguer J, Pujol-Borrell R, 

Borràs FE, Vives-Pi M. 

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. 

CLIN EXP IMMUNOL 2009 Dec 17 

IF: 3,009 

Martínez MA 

Progress in the therapeutic applications of siRNAs against HIV-1. 

Methods Mol Biol 2009;487:343-68 


Matamoros, T; Nevot, M; Martinez, MA; Menendez-Arias, L 

Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine 

excision and discrimination. 

J BIOL CHEM 2009 Nov 20;284(47):32792-802. Epub 2009 Sep 29. 

IF: 5,328 

Mikhail Popkov , Beatriz Gonzalez , Subhash Sinha , Carlos Barbas, III 

Instant immunity through chemically programmable Instant immunity through chemically programmable vaccination and 

covalent self-assembly. 

P NATL ACAD SCI USA 2009; Mar 17;106(11):4378-83. 

IF: 9,432 

Moreno, Clotet, Sarría, Ortega, Leal, Rodriguez-Arrondo, Sánchez-de la Rosa, Allegro Study Group. 

Prevalence of CCR5-tropic HIV-1 among treatment-experienced individuals in Spain. 

HIV CLIN TRIALS 2009 Nov-Dec;10(6):394-402. 

IF: 1,626 

Mothe, B; Ibarrondo, J; Llano, A; Brander, C 

Virological, immune and host genetics markers in the control of HIV infection 

DIS MARKERS 2009; 27:105-120 

IF: 2,026 

Navarro-Muñoz M, Pérez V, Ara J, Ibernon M, Bonet J, Bayés B, Pastor MC, Casado J, Serra A, Fluvià L, Núñez A, López D, Romero 

R. 

Urinary peptide profiling as a possible non-invasive tool for the differential diagnosis of glomerular disease. 

CLIN J AM SOC NEPHRO 2009; 

IF: 4,844 

Negredo, E; Miro, O; Rodriguez-Santiago, B; Garrabou, G; Estany, C; Masabeu, A; Force, L; Barrufet, P; Cucurull, J; Domingo, P; 

Alonso-Villaverde, C; Bonjoch, A; Moren, C; Perez-Alvarez, N; Clotet, B 

Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse-Transcriptase Inhibitor-Sparing Strategy: 

Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA) 

CLIN INFECT DIS 2009; 49:892-900 

IF: 8,195 

Pellitero S, Reverter J-L, Granada ML, Pizarro E, Pastor MC, Tàssies D, Reverter JC, Salinas I, Sanmarti A. 

Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the presence and the 

morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control 

EUR J ENDOCRINOL 2009; 160: 925-932. 

IF: 3,539 

Pujol-Borrell, R; Herrero-Mata, MJ; Palou, E; Armengol, MP 

Immunological Senescence and Thymic Function in Transplantation 

TRANSPLANTATION 2009-AUG 15; 88 (3): S8-S13 

IF: 3,498 

Reverter JL, Nadal J, Fernández-Novell JM, Ballester J, Ramió-Lluch L, Rivera MM, Elizalde J, Abengoechea S, Guinovart JJ, 

Rodríguez-Gil JE. 

Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy. 

INVEST OPHTH VIS SCI 2009 Mar;50(3):1378-82. Epub 2008 Oct 31 

IF: 3,431 

Ricos, C; Perich, C; Minchinela, J; Alvarez, V; Simon, M; Biosca, C; Domenech, M; Fernandez, P; Jimenez, CV; Garcia-Lario, JV; Cava, 

F 

Application of biological variation - a review 

BIOCHEM MEDICA 2009;19:250-259 

IF: 0,660 

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. 

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human 

immunodeficiency virus co-infection. 


J VIRAL HEPATITIS 2009; 16:513-518 

IF: 3,348 

Sobrino, T; Arias, S; Rodriguez-Gonzalez, R; Brea, D; Silva, Y; de la Ossa, NP; Agulla, J; Blanco, M; Pumar, JM; Serena, J; Davalos, A; 

Castillo, J 

High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage 

J CEREBR BLOOD F MET 2009; 29:1968-1974 

IF: 5,457 

Thiebaut, R; Kotti, S; Jung, C; Merlin, F; Colombel, JF; Lemann, M; Almer, S; Tysk, C; O'Morain, M; Gassull, M; Binder, V; Finkel, Y; 

Pascoe, L; Hugot, JP 

TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort 

AM J GASTROENTEROL 2009-FEB; 104 (2): 384-391 

IF: 6,012 

van Luin, M; Bannister, WP; Mocroft, A; Reiss, P; Di Perri, G; Peytavin, G; Molto, J; Karlson, A; Castagna, A; Beniowski, M; 

Lundgren, JD; Burger, DM 

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA 

study 

ANTIVIR THER 2009; 14 (1): 75-83 

IF: 4,322 

Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R, Schneidewind A, Power KA, Toth I, Frahm N, Alter G, Brander C, 

Carrington M, Walker BD, Altfeld M, Heckerman D, Allen TM. 

Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in 

highly conserved regions of human immunodeficiency virus type 1. 

J VIROL 2009 Feb;83(4):1845-55. Epub 2008 Nov 26 

IF: 5,150 

Projectes 


ABAD CAPA, JORGE - PNEUMOLOGIA 

SEPAR - Núm. Exp.: 889 

Análisis de polimorfismos genéticos en el fenotipo SAHS-Obesidad. 

Durada: 3 anys - (2009-2012) 

Import Concedit: 12.000 € 

ARENILLAS LARA, JUAN FRANCISCO – NEUROLOGIA 

FIS - Núm. Exp.: PI070393 

Mecanismos básicos implicados en el desarrollo y la progresión de la aterosclerosis intracraneal asintomática: estudio de base 

poblacional. 

Durada: 3 anys - (2007-2010) 


AUSINA RUIZ, VICENÇ - MICROBIOLOGIA 

Ministerio de Ciencia e Innovación - Núm. Exp.: TRA2009_0370_02 

Validación de la encapsulación de principios activos en micro- y nanopartículas y su uso para la fabricación en desinfectantes de 

larga duración. 

Durada: 3 anys - (2010-2013) 


BAYES GENIS, BEATRIU - NEFROLOGIA 


Papel de la autoinmunidad en el desarrollo de la diabetes mellitus postrasplante renal (DMPT): Marcadores humorales, genéticos 

y linfocitos T reguladores. 

Durada: 3 anys - (2007-2010) 



BLANCO ARBUES, JULIAN MIGUEL - FUNDACIÓ IRSICAIXA 

FIPSE - Núm. Exp.: 36600/06 

Caracterización de la proteasas ejecutoras de la muerte celular inducida por VIH. 

Durada: 3 anys - (2006-2009) 



FIPSE - Núm. Exp.: 36750/08 

Evaluación de la adenosina desaminasa como molécula coestimuladora de la actividad linfocitaria en una vacuna terapéutica del 

VIH. 

Durada: 3 anys - (2008-2011) 


BORRAS SERRES, FRANCESC ENRIC - IMMUNOLOGIA / BST / LIRAD 


Coordinación entre las células dendríticas mieloides y plasmacitoides en la generación de la respuesta inmune. 

Durada: 3 anys - (2006-2009) 


BRANDER , CHRISTIAN - FUNDACIÓ IRSICAIXA 

FIPSE - Núm. Exp.: 36-0737-09 

Caracterización de los factores inmunológicos, genéticos y virales que determinan la pérdida del control de la infección por el VIH 

en 

la población de progresores lentos (LTNP) 

Durada: 3 anys - (2009-2012) 


CABRERA NAVARRO, CECILIA - FUNDACIÓ IRSICAIXA 

FIPSE - Núm. Exp.: 36725/08 

Caracterización de los factores virales e inmunológicos que protegen las células CD4 en pacientes VIH+ sin tratamiento que 

presentan niveles de CD4 constantes y replicación viral elevada. 

Durada: 3 anys - (2008-2011) 


ESTE ARAQUE, JOSE ANDRES - FUNDACIÓ IRSICAIXA 


Integrinas en la infección viral. 

Durada: 3 anys - (2006-2009) 


GASULL DALMAU, TERESA - NEUROLOGIA 

MEC - Núm. Exp.: SAF2007-62559 

Papel de los rafts lipídicos en la neurodegeneración producida por la excesiva activación de los receptores glutamatérgicos: 

protección por estatinas. 

Durada: 3 anys - (2007-2010) 


GASULL DALMAU, TERESA - NEUROLOGIA 

Pfizer - Núm. Exp.: --- 

Atorvastatin and one of its specific matabolites might protect from NMDA-Induced neuronal death by altering the association of 

NMDA receptors to lipids rafts. 

Durada: 2 anys - (2007-2009) 

Import Concedit: 45.558,9 € 

MAÑE ALMERO, JOSEP - APARELL DIGESTIU 

MEC - Núm. Exp.: BFU2006-15063-C03-02-BFI 

Activación de TLR-2 y función barrera en el colon. Caracterización de los mecanismos moleculares y celulares implicados. 

Durada: 3 anys - (2006-2009) 


MARTINEZ CACERES, EVA MARIA - IMMUNOLOGIA / BST / LIRAD 

Fundació La Marató de TV3 - Núm. Exp.: 072410 


TOLERVIP-MS: inducció de tolerància en esclerosi múltiple amb cèl·lules dendrítiques tractades amb pèptid intestinal vasoactiu i 

carregades amb pèptids de la mielina. 

Durada: 3 anys - (2007-2010) 


MARTINEZ CACERES, EVA MARIA - IMMUNOLOGIA / BST / LIRAD 

Fundació GAEM - Núm. Exp.: 01032007 

Tolervip-MS: Inducció de tolerància en Esclerosi múltiple amb cèl·lules dendrítiques tractades amb pèptid intestinal vasoactiu i 

carregades amb pètids de la mielina. 

Durada: 3 anys - (2007-2010) 


MARTINEZ DE LA SIERRA, MIGUEL ANGEL - FUNDACIÓ IRSICAIXA 


Mutagénesis letal del VIH-1 como una nueva estrategia antirretroviral. 

Durada: 3 anys - (2007-2010) 


MARTINEZ PICADO, JAVIER - FUNDACIÓ IRSICAIXA 

FIPSE - Núm. Exp.: 36621/06 

SLC22 y SLC21: Nuevos genes implicados en el transporte celular de fármacos antirretrovirales en linfocitos. 

Durada: 3 anys - (2007-2010) 


MATILLA DUEÑAS, ANTONI - NEUROLOGIA 

Ministerio de Educación y Ciencia - Núm. Exp.: BFU2008-00527 

Identificación de genes y rutas moleculares directamente reguladas por ataxina_1. 

Durada: 3 anys - (2008-2011) 



COMISSIÓ EUROPEA - Núm. Exp.: LHSM-CT-2004-503304 

European integrated project on spinocerebellar ataxias (EUROSCA): Pathogenesis, genetics, animal models and therapy. 

Durada: 5 anys - (2004-2009) 



FIS - Núm. Exp.: CP08/00027 

Investigación de las bases moleculares neurodegenerativas en la ataxia espinocerebelosa tipo 1 (SCA1) 

Durada: 3 anys - (2008-2011) 


PLANAS VILA, RAMON - APARELL DIGESTIU 


Bloqueo del receptor de endocanabinoides CB1 por SR141716A en ratas cirróticas con ascitis. Efecto sobre la progresión a cirrosis, 

la hipertensión portal, translocación bacteriana y encefalopatía. 

Durada: 3 anys - (2008-2011) 


ROLDAN SANCHEZ, JUAN - PNEUMOLOGIA 


Mecanismos Genéticos y Celulares en Fibrosis Pulmonar. 

Durada: 3 anys - (2007-2010) 


SANMARTI SALA, ANNA - ENDOCRINOLOGIA I NUTRICIÓ 


Mecanismos patogénicos implicados en la aparición de enfermedad autoinmunitaria tiroidea. Células reguladoras y señales 

moleculares de peligro. 

Durada: 4 anys - (2005-2009) 



SARRIAS FORNÉS, MARIA ROSA - IMMUNOLOGIA IGTP 

FIS - Núm. Exp.: CP08/00124 

Papel de las proteínas scavenger Spalpha/AIM en la respuesta del huésped a la infección bacteriana. 

Durada: 3 anys - (2008-2011) 




Estudio de las propiedades inmunoreguladoras de la proteína scavenger Sp_ en la respuesta anti-infecciosa. 

Durada: 3 anys - (2007-2010) 


VIVES PI, MARTA - IMMUNOLOGIA / BST / LIRAD 


Papel de Reg (Regenerating gene) como nuevo autoantígeno, marcador de autoinmunidad y de regeneración celular en la 

diabetes tipo 1. 

Durada: 3 anys - (2006-2009) 



CARDONA IGLESIAS, PERE JOAN - MICROBIOLOGIA 

BILL & MELINDA GATES FOUNDATION - Núm. Exp.: 37885 

Preclinical and clinical evaluation of a post-exposure TB vaccine (proposal no.82) 

Durada: 5 anys - (2005-2010) 


CASABONA BARBARA, JORDI - CEEISCAT 

COMISSIÓ EUROPEA - Núm. Exp.: 20091211 

HIV community-based testing practices in Europe. HIV-COBATEST. 

Durada: 3 anys - (2010-2013) 


DOMINGUEZ BENITEZ, JOSE ANTONIO - MICROBIOLOGIA 

FUCAP - Núm. Exp.: -- 

Utilidad de la cuantificación de linfócitos T sensibilizados frente a antígenos específicos de mycobacterium tuberculosis presentes 

en lavado broncoalveolar para el diagnóstico de la tuberculosis pulmonar. 

Durada: 3 anys - (2007-2010) 



B•R•A•H•M•S Aktiengesellschaft - Núm. Exp.: --- 

Clinical Evaluation of the In Vitro Diagnostic Product BRAHMS PCT direct 

Durada: 2 anys - (2008-2010) 


LAUZURICA VALDEMOROS, RICARDO - NEFROLOGIA 

FIS - Núm. Exp.: EC07/90472 

Estudio piloto de selección del regimen inmunosupresor basado en anti-calcineurinico o libre de anti-calcineurinico dependiendo 

de la aloreactividad celular donante-específica mediante técnica de elispot en receptores de un injerto redal de bajo riesgo. 

Durada: 3 anys - (2007-2010) 


MILLAN TORNE, MONICA - NEUROLOGIA 

FIS - Núm. Exp.: PS09/01638 

Efecto de la recanalización arterial y del postcondicionamiento isquémico sobre el daño por reperfusión en pacientes con 

oclusión proximal de la arteria cerebral media 

Durada: 3 anys - (2009-2012) 


MONSO MOLAS, EDUARD - PNEUMOLOGIA 



Caracterización y efectos de la inflamación y colonización bronquial en la enfermedad pulmonar obstructiva crónica. 

Durada: 3 anys - (2006-2009) 



Instituto de Salud Carlos III - Núm. Exp.: GR09/0001 

La gripe pandémica A/H1N1 en España. Caracterización clínica y biológica. Un estudio piloto en 5 hospitales (Estudio 5H). 

Durada: 3 anys - (2009-2012) 

Import Concedit: 0 € 

ROMEU FONTANILLAS, JOAN - MEDICINA INTERNA - VIH 

FIS - Núm. Exp.: EC07/90672 

Tratamiento antirretroviral una vez al día en pacientes con infección por el VIH-1 no tratados previamente y con cifras de 

linfocitos CD$+ inferioresa 100 cel/MM3. Estudio prospectivo aleatorizado, multicéntrico y abierto. Estudio ADVANZ-3. 

Durada: 3 anys - (2007-2010) 



ABAD ESTEVE, ALBERT - ONCOLOGIA MÈDICA 

FIS - Núm. Exp.: PS09/01463 

Implicación de los TLRS en la tumorogénesis intestinal: Determinación de biomarcadores humanos, validación del modelo animal 

y análisis de perfiles genéticos por micromatrices. 

Durada: 3 anys - (2009-2012) 


BALIBREA DEL CASTILLO, JOSÉ MARÍA - CIRURGIA GENERAL I DIGESTIVA 

FIS - Núm. Exp.: PS09/00759 

Estudio comparativo de la respuesta inflamatoria local y sistémica tras gastrectomía abierta o laparoscópica por cáncer 

Durada: 3 anys - (2009-2012) 


BEYER , KATRIN - ANATOMIA PATOLÒGICA 

Fundació La Marató de TV3 - Núm. Exp.: 06/1410 

Expressió diferencial d’isoformes d’alfa-sinucleïna: un possible marcador en sang perifèrica de la malaltia de Parkinson. 

Durada: 3 anys - (2006-2009) 


BEYER , KATRIN - ANATOMIA PATOLÒGICA 

Ministerio de Ciencia e Innovación - Núm. Exp.: CP09/00102 

Expresión diferencial de isoformas de beta-sinucleína en cerebro y su detección en sangre como posible biomarcador diagnóstico 

para la enfermedad de Parkinson 

Durada: 3 anys - (2009-2012) 




Herramientas para la cuantificación de la respuesta humoral protectiva contra las proteínas gp120 y gp41 del VIH. Análisis de 

indicadores de protección y diseño racional de inmunógenos. 

Durada: 3 anys - (2008-2011) 


BOFILL SOLIGUER, MARGARITA - FUNDACIÓ IRSICAIXA 


Impacto de la infección por el VIH sobre acción de la IL-12 e IL-18 sobre monocitos y macrófagos: relevancia sobre el control de 

Mycobacterium tuberculosis y Mycobacterium avium. 

Durada: 3 anys - (2008-2011) 


BORRAS SERRES, FRANCESC ENRIC - IMMUNOLOGIA / BST / LIRAD 

FIS - Núm. Exp.: PS09/00229 

Estrategias para la inducción de tolerancia y prevención de la Nefropatía Crónica del Transplante. SUBPROYECTO 2: Evaluación del 


uso de exosomas obtenidos de fluidos biológicos como aloantígenos para la inducción de tolerancia en trasplante 

Durada: 3 anys - (2009-2012) 


CABRE GELADA, EDUARD - APARELL DIGESTIU 

FIS - Núm. Exp.: PS09/01294 

Perfil genético funcional en la enfermedad de CROHN. Efecto sobre el desarrollo de recurrencia post-quirúrgica 

Durada: 3 anys - (2009-2012) 


CABRERA NAVARRO, CECILIA - FUNDACIÓ IRSICAIXA 


Efecto del tratamiento con T-20 en las funciones de la envuelta viral: relaciones de fusogenicidad, patogenicidad e infectividad en 

virus T-20-resistentes. 

Durada: 3 anys - (2007-2010) 




LATENT TUBERCULOSIS: New tools for the detection and clearance of dormant Mycobacterium tuberculosis. (StopLATENT-TB) 

Durada: 3 anys - (2007-2010) 




Demostración de la hipótesis dinámica de la infección tuberculosa latente. 

Durada: 3 anys - (2008-2011) 



Comissió Europea - Núm. Exp.: CURE TB 

New Drugs to Cure TB: Pre-clinical Validation of Optimised Drug leads for the Treatment and Cure of Resistant and Persistent 

Tuberculosis. 

Durada: 3 anys - (2010-2013) 


DAVALOS ERRANDO, ANTONI - NEUROLOGIA 


Sobrecarga de hierro y toxicidad neurovascular: Estudio clínico y experimental en la isquémia y reperfusión cerebral. 

Durada: 3 anys - (2006-2009) 


DAVALOS ERRANDO, ANTONI - NEUROLOGIA 

CIDEM - Núm. Exp.: RDITSCON07-4-2006 

Disseny de models per al desenvolupament de noves Teràpies Neuro reparadores e Ictus. 

Durada: 3 anys - (2007-2010) 



SEPAR - Núm. Exp.: -- 

Utilidad de la cuantificación de linfocitos T sensibilizados frente a antígenos específicos de Mycobacterium tuberculosis en la 

monitorización del tratamiento de la tuberculosis y de la profilaxis de la infección tuberculosa. 

Durada: 3 anys - (2006-2009) 




Detección, identificación de Mycobacterium tuberculosis, caracterización molecular de la resistencia a los principales 

antituberculosos en muestra clínica directa mediante pirosecuenciación. Aplicabilidad en el estudio de la clonalidad de las cepas. 

Durada: 3 anys - (2007-2010) 





Utilidad de la pirosecuenciación en la detección, identificación de Mycobacterium tuberculosis y caracterización molecular de la 

resistencia a los principales antituberculosos en muestra clínica directa. 

Durada: 4 anys - (2007-2011) 


IBARRONDO VALLEJO, FRANCISCO JAVIER - FUNDACIÓ IRSICAIXA 

FIS - Núm. Exp.: PS09/00283 

Definition of protective immunity to HIV using Toggled peptides 

Durada: 3 anys - (2009-2012) 


MARTINEZ BALIBREA, EVA - ONCOLOGIA MÈDICA 

Fundación Privada Olga Torres - Núm. Exp.: FOT 2009-2011 

Estudio del papel de la isoforma M2 de Piruvato quinasa (PK-M2) en la respuesta y resistencia a oxaliplatino en líneas celulares y 

pacientes con cáncer colorrectal avanzado. 

Durada: 3 anys - (2008-2011) 


MARTRO CATALA, ELISA - MICROBIOLOGIA 

Ministerio de Ciencia e Innovación - Núm. Exp.: CP09/00044 

Impacto de la variabilidad genética del VHC-1 y de los cofactores del hospedador basales en la probabilidad de respuesta a la 

teràpia antivírica combinada de la hepatitis C crónica. 

Durada: 3 anys - (2009-2012) 


PUJOL BORRELL, RICARDO - IMMUNOLOGIA / BST / LIRAD 


Fisiopatología y diagnóstico de las enfermedades autoinmunes: Tiroiditis, Diabetes y Esclerosis Múltiple, un abordaje inspirado en 

la biologia de sistemas. 

Durada: 3 anys - (2008-2011) 


ROMERO GONZALEZ, RAMÓN - NEFROLOGIA 


Aplicaciones clínico-diagnósticas de la proteómica en las nefropatías glomerulares proteinúricas. 

Durada: 4 anys - (2006-2010) 


RUIZ MANZANO, JOAN - PNEUMOLOGIA 

SOCAP - Núm. Exp.: 

Estudi de la utilitat de la determinació dual del número de cèl•lules T productores d’interferó gamma i interleuquina 2 en la 

monitorització del tractament de la tuberculosi i de la profilaxi de la infecció tuberculosa. 

Durada: 3 anys - (2008-2011) 




Mecanismes moleculars implicats en la prevenció de l'aterosclerosi mediada per LXR I RXR. subprojecte 3: Paper d´aim en 

l´activació del macròfag i desenvolupament de cèl.lules espumoses. 

Durada: 3 anys - (2008-2011) 


SOLDEVILA MADORELL, BERTA - ENDOCRINOLOGIA I NUTRICIÓ 

Societat Catalana d'Endocrinologia i Nutrició - Núm. Exp.: 

Mecanismes patogènics implicats en l’aparició de malaltia autoimmunitària tiroïdal en pacients amb melanoma maligne tractats 

amb interferó-alfa. Paper de les cèl·lules T reguladores. 

Durada: 1 anys - (2009-2010) 


TOR AGUILERA, JORDI - MEDICINA INTERNA - DESINTOXICACIÓ 



Evaluación no invasiva de la fibrosis hepática en pacientes coinfectados por el VHC y VIH. Correlación del patrón histológico con la 

determinación de proteinas relacionadas con la formación de la matriz extracelular. 

Durada: 4 anys - (2005-2009) 


VIVES PI, MARTA - IMMUNOLOGIA / BST / LIRAD 

FIS - Núm. Exp.: PS09/00253 

Prevención y remisión de la diabetes tipo 1 mediante inmunoterapia con células dendríticas autólogas pulsadas con cuerpos 

apoptoticos antígeno específicos 

Durada: 3 anys - (2009-2012) 



CÀNCER 

Publicacions 


Armengol C, Cairo S, Fabre M, Buendia MA. 

Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model. 

INT J BIOCHEM CELL B 2009 Jul 29. [Epub ahead of print] 

IF: 4,887 

Baranovskaya S, Martin Y, Alonso S, Pisarchuk KL, Falchetti M, Dai Y, Khaldoyanidi S, Krajewski S, Novikova I, Sidorenko YS, 

Perucho M, Malkhosyan SR. 

Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon 

cancer with microsatellite instability. 

CLIN CANCER RES 2009 Jul 15;15(14):4531-7. 

IF: 6,747 

Buschbeck M, Uribesalgo I, Wibowo I, Rué P, Martin D, Gutierrez A, Morey L, Guigó R, López-Schier H, Di Croce L. 

The histone variant macroH2A is an epigenetic regulator of key developmental genes. 

NAT STRUCT MOL BIOL 2009 Oct;16(10):1074-9. Epub 2009 Sep 6. 

IF: 12,273 

Carbajosa G, Trigo A, Valencia A, Cases I. 

Bionemo: molecular information on biodegradation metabolism. 

NUCLEIC ACIDS RES 2009 Jan;37(Database issue):D598-602. Epub 2008 Nov 5. 

IF: 7,479 

Mayor R, Casadomé L, Azuara D, Moreno V, Clark SJ, Capellà G, Peinado MA. 

Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non invasive 

biomarker of disease. 

BRIT J CANCER 2009 May 19;100(10):1534-9. Epub 2009 Apr 21. 

IF: 4,346 

Miller SJ, Jessen WJ, Mehta T, Hardiman A, Sites E, Kaiser S, Jegga AG, Li H, Upadhyaya M, Giovannini M, Muir D, Wallace MR, 

Lopez E, Serra E, Nielsen GP, Lazaro C, Stemmer-Rachamimov A, Page G, Aronow BJ, Ratner N. 

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. 

EMBO MOL MED 2009 Jul;1(4):236-48. 

IF: 0,000 

Morales C, García MJ, Ribas M, Miró R, Muñoz M, Caldas C, Peinado MA. 

DHFR amplification and sensitization to methotrexate of methotrexate resistant colon cancer cells. Molecular Cancer 

Therapeutics. 

MOL CANCER THER 2009; 8:424-432 

IF: 4,953 

Pros E, Fernández-Rodríguez J, Benito L, Ravella A, Capellá G, Blanco I, Serra E, Lázaro C. 

Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatment. 

EUR J HUM GENET 2009 Nov 25. [Epub ahead of print] 

IF: 3,564 

Pros E, Fernández-Rodríguez J, Canet B, Benito L, Sánchez A, Benavides A, Ramos FJ, López-Ariztegui MA, Capellá G, Blanco I, Serra 

E, Lázaro C. 

Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. 

HUM MUTAT 2009 Mar; 30(3):454-62. 


IF: 6,887 

Rangel A, Madroñal N, Gruart i Massó A, Gavín R, Llorens F, Sumoy L, Torres JM, Delgado-García JM, Del Río JA. 

Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of 

prion mutant mice. 

PLOS ONE 2009 Oct 26;4(10):e7592. 

IF: 4,351 

Rosell, R 

BRCA1 gene and sensitivity to lung cancer chemotherapy 

J THORAC ONCOL 2009-SEP; 4 (9): S53-S54 

IF: 4,547 

Rosell, R; Moran, T; Queralt, C; Porta, R; Cardenal, F; Camps, C; Majem, M; Lopez-Vivanco, G; Isla, D; Provencio, M; Insa, A; 

Massuti, B; Gonzalez-Larriba, JL; Paz-Ares, L; Bover, I; Garcia-Campelo, R; Moreno, MA; Catot, S; Rolfo, C; Reguart, N; Palmero, R; 

Sanchez, JM; Bastus, R; Mayo, C; Bertran-Alamillo, J; Molina, MA; Sanchez, JJ; Taron, M 

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer. 

NEW ENGL J MED 2009-SEP 3; 361 (10): 958-U38 

IF: 47,050 

Rosell, R; Ramirez, JL; de Aguirre, I; Benlloch, S; Cuello, M; Cardona, AF; Moran, T; Carcereny, E; Massuti, B; Taron, M; 

Gonzalez, N; Porta, R 

The nicotinic acetylcholine receptor (nAChR) subunit alpha3 (CHRNA3) polymorphism in advanced non-small-cell lung cancer 

(NSCLC) patients (p) with EGFR mutations treated with erlotinib 


IF: 4,547 

Rosell, R; Wei, J; Taron, M 

Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer 

CLIN LUNG CANCER 2009-JAN; 10 (1): 8-9 

IF: 1,509 

Servitja JM, Pignatelli M, Maestro MA, Cardalda C, Boj SF, Lozano J, Blanco E, Lafuente A, McCarthy MI, Sumoy L, Guigó R, Ferrer J. 

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic 

islets and liver. 

MOL CELL BIOL 2009 Jun;29(11):2945-59. Epub 2009 Mar 16. 

IF: 6,057 

Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernández-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, 

Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y. 

Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid 

tumors. 

INT J CANCER 2009 Sep 15;125(6):1243-9. 

IF: 4,722 

Taron, M; Benlloch, S; Chaib, I; Mendez, P; Rosell, R 

Mechanisms of drug resistance with cytotoxics 


IF: 4,547 

Trigo A, Valencia A, Cases I. 

Systemic approaches to biodegradation. 

FEMS MICROBIOL REV 2009 Jan;33(1):98-108. Epub 2008 Nov 13. 

IF: 9,783 

Yamamoto F, Yamamoto M, Blancher A. 

Generation of histo-blood group B transferase by replacing the N-acetyl-d-galactosamine recognition domain of human A 

transferase with the galactose-recognition domain of evolutionarily related murine alpha1,3-galactosyltransferase. 

TRANSFUSION 2009 Nov 20. [Epub ahead of print] 

IF: 2,982 



Alvarez, M; Lezcano, C; Ponton, JL; Bonafont, X 

Study of granulocyte colony-stimulating factor use in an onco-haematology unit 

PHARM WORLD SCI 2009-FEB; 31 (1): 126-126 

IF: 0,919 

Barnadas, A; Gil, M; Gonzalez, S; Tusquets, I; Munoz, M; Arcusa, A; Prieto, L; Margeli-Vila, M; Moreno, A 

Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial 

BRIT J CANCER 2009-feb-03; 100 (3): 442-449 

IF: 4,346 

Bassas-Vila J,. 

Patrones tumorales en dermatopatología (A) 

PIEL 2009;24:446-450 

Bosch F, Abrisqueta P, Villamor N, Terol MJ, González-Barca E, Ferra C, González Diaz M, Abella E, Delgado J, Carbonell F, García 

Marco JA, Escoda L, Ferrer S, Monzó E, González Y, Estany C, Jarque I, Salamero O, Muntañola A, Montserrat E. 

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic 

lymphocytic leukemia. 

J CLIN ONCOL 2009; 27(27):4578-84. 

IF: 17,793 

Carcereny, E; Moran, T; Felip, E; Borghaei, H; Fitzgerald, T; Clark, J; Guan, SH; Hsu, K; Beckman, R; Yan, L; Rosell, R; Johnson, DH 

An open label, randomized phase I/IIA trial evaluating MK-0646, an anti-IGF-1R monoclonal antibody (MoAB), in combination with 

erlotinib for patients with recurrent non-small cell lung cancer (NSCLC) 


IF: 4,547 

Cardenal, F; Moran, T; Queralt, C; Porta, R; Camps, C; Majem, M; Lopez-Vivanco, G; Isla, D; Provencio, M; Sanchez, JJ; Taron, M; 

Rosell, R 

Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor 

receptor (EGFR) mutations 


IF: 4,547 

Cardona, AF; Reguart, N; Reveiz, L 

Wood-Smoke Exposure (WSE) as a Predictor of Response and Survival in Erlotinib-Treated Non-small Cell Lung Cancer (NSCLC) 

Patients 

J THORAC ONCOL 2009-JAN; 4 (1): 142-143 

IF: 4,547 

De la Rubia J, Montesinos P, Martino R, Jarque I, Rovira M, Vázquez L, López J, Batlle M, de la Cámara R, Julià A, Lahuerta JJ, 

Debén G, Díaz J, García R, Sanz MA. 

Imipenm/cilastatin wtih or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: 

results of a Spanish multicenter study. 

BIOL BLOOD MARROW TR 2009; 15: 512-516 

IF: 3,149 

Diez-Martin, JL; Balsalobre, P; Re, A; Michieli, M; Ribera, JM; Canals, C; Conde, E; Rosselet, A; Gabriel, I; Varela, R; Allione, B; 

Cwynarski, K; Genet, P; Espigado, I; Biron, P; Schmitz, N; Hunter, AE; Ferrant, A; Guillerm, G; Hentrich, M; Jurado, M; Fernandez, P; 

Serrano, D; Rossi, G; Sureda, A 

Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral 

blood stem cell transplantation 

BLOOD 2009-juny-04; 113 (23): 6011-6014 

IF: 10,555 

Estevez, LG; Fortes, JL; Adrover, E; Peiro, G; Margeli, M; Castella, E; Cuevas, JM; Bernet, L; Segui, MA; Andreu, X 

Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of 

biological markers in a GEICAM phase II study 

CLIN TRANSL ONCOL 2009-JAN; 11 (1): 54-59 

IF: 1,146 


Felip, E; Massuti, B; Maestre, JA; Alonso, G; Paniagua, JMR; Gonzalez-Larriba, JL; Camps, C; Isla, D; Overbeck, T; Costas, E; Sanchez, 

JJ; Rosell, R 

A phase III randomized trial of surgery (S) alone, or preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy followed by S, 

or S followed by adjuvant (adj) PC chemotherapy in early stage non-small cell lung cancer (NSCLC): NATCH follow-up data 


IF: 4,547 

Ferra C, Ribera JM. Unrelated 

Transplants for High-Risk Adult Acute Lymphoblastic Leukemia. 

EUR J HAEMATOL 2009; 3 

IF: 2,345 

Ferrándiz C, Fuente MJ, Ferrándiz L, Carrascosa JM 

Basal cell carcinoma 

CANCER TREAT REV 2009;146:263-78.(R) 

IF: 4,980 

Ferrando-Martinez, S; Franco, JM; Hernandez, A; Ordonez, A; Gutierrez, E; Abad, A; Leal, M 

Thymopoiesis in elderly human is associated with systemic inflammatory status 

AGE 2009; 31:87-97 

IF: 5,839 

Fuente MJ, Leal L, Ribera M 

Efectos secundarios cutáneos de los tratamientos sistémicos del cáncer (I): quimioterapia (R) 

PIEL 2009;24:368-379 

Gallardo F, García-Muret P, Servitje O, Estrach T, Bielsa I , Solar A et al 

Cutaneous lymphomas showing prominente granulomatous component: clinicopathological features in a series of 16 cases 

J EUR ACAD DERMATOL 2009;23:648-650 (A) 

IF: 2,787 

García Marco JA, Panizo C, Sánchez García E, Deben G, Alvarez-Larran A, González Barca E, Sancho JM, Peñarrubia MJ, García- 

Cerecedo T, García Vela JA. 

Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma. 

CANCER 2009; 115: 1892-1898. 

Garcia-Olive, I; Monso, E; Andreo, F; Sanz, J; Castella, E; Llatjos, M; de Miguel, E; Astudillo, J 

Sensitivity of linear endobronchial ultrasonography and guided transbronchial needle aspiration for the identification of nodal 

metastasis in lung cancer staging. 

ULTRASOUND MED BIOL 2009-AUG; 35 (8): 1271-1277 

IF: 2,021 

Garrido, P; Rosell, R; Massuti, B; Cardenal, F; Alberola, V; Domine, M; Maeztu, I; Ramos, A; Arellano, A 

Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase 

II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy 

CLIN LUNG CANCER 2009-MAY; 10 (3): 180-186 

IF: 1,509 

Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D, Doubek M, Mayer J, Piatkowska-Jakubas B, Skotnicki AB, 

Dombret H, Ribera JM, Piccaluga PP, Czerw T, Kyrcz-Krzemien S, Holowiecki J. 

Status of minimal residual disease determines outcome of autologous hematopoietic stem cell transplantation in adult acute 

lymphoblastic leukemia. 

BONE MARROW TRANSPL 2009; OCT 308. 

IF: 2,998 

Hidalgo, M; Abad, A; Aranda, E; Diez, L; Feliu, J; Gomez, C; Irigoyen, A; Lopez, R; Rivera, F; Rubio, C; Sastre, J; Tabernero, J; Diaz- 

Rubio, E 

Consensus on the treatment of pancreatic cancer in Spain 

CLIN TRANSL ONCOL 2009-MAY; 11 (5): 290-301 

IF: 1,146 

JM Ribera, A Oriol, M González, B Vidriales, S Brunet, J Esteve, E del Potro, C Rivas, MJ Moreno, M Tormo, V Martín-Reina, J Sarrá, 


R Parody, J Pérez de Oteyza, E Bureo, MT Bernal on behalf of the Programa Español de Tratamiento en Hematología (PETHEMA) 

and Grupo Español de Trasplante Hemopoyético (GETH) Groups. 

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia 

chromosome-positive acute lymphoblastic leukemia. 

HAEMATOL-HEMATOL J 2009; Oct 1 

IF: 6,416 

JM Ribera, A Oriol. 

Acute Lymphoblastic Leukemia in Adolescents and Young Adults. 

HEMATOL ONCOL CLIN N 2009; 23:1033-42 

IF: 2,054 

Juncà J, Moreno M, Mate JL, Milla F. 

Concomitant diagnosis of acute myeloid leukaemia and a chronic lymphoproliferative disorder with AA amyloidosis as a final 

event. 

MED CLIN-BARCELONA 2009 Sep 17 

IF: 1,231 

Leal L, Fuente MJ, Ribera M. 

Efectos secundarios cutáneos de los fármacos antineoplásicos(II): 

Inhibidores de cinasas y anticuerpos monoclonales 

PIEL 2009;24:427-439 (R) 

Margelí, M. 

Supervivencia tras la primera recidiva en cáncer de mama, ¿se puede individualizar 

MED CLIN-BARCELONA 2009;133:506-7. 

IF: 1,231 

Martin-Algarra, S; Espinosa, E; Rubio, J; Lopez, JJL; Manzano, JL; Carrion, LA; Plazaola, A; Tanovic, A; Paz-Ares, L 

Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma 

EUR J CANCER 2009-MAR; 45 (5): 732-735 

IF: 4,121 

Martin, M; Lluch, A; Ruiz-Simon, A; Ribelles, N; Ruiz-Borrego, M; Rodriguez-Lescure, A; Munoz, M; Ramos, M; Gonzalez, S; 

Margeli, M 

First safety data from a randomised phase III trial comparing adjuvant epirubicin-cyclophosphamide -> docetaxel (EC -> T) vs ET 

capecitabine (X) in N plus operable breast cancer (BC) 

BREAST 2009-MAR; 18: S55-S55 

IF: 2,087 

Martínez A, Xicoy B, Ferrà C, Ribera JM. 

Sustained remission following autologous recovery after non-myeloablative stem cell transplantation in a patient with Hodgkin's 

lymphoma. 

MED CLIN-BARCELONA 2009 May 16;132(18):723-4. Epub 2009 Mar 13 

IF: 1,231 

Martínez A, Xicoy B, Flores A, JM Ribera. 

Remisión completa continuada tras un trasplante alogénico con acondicionamiento de intensidad reducida no mieloablativo con 

recuperación antóloga en una paciente con linfoma de Hodgkin en recidiva precoz tras trasplante autogénico de progenitores 

hematopoyéticos 

MED CLIN-BARCELONA 2009; Jun 10 

IF: 1,231 

Martinez C; Solano C; Ferra C; Sampol A; Valcarcel D; Perez-Simon JA 

Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study 

BIOL BLOOD MARROW TR 2009-MAY; 15 (5): 639-642 

IF: 3,149 

Martinez-Balibrea, E; Martinez-Cardus, A; Musulen, E; Gines, A; Manzano, JL; Aranda, E; Plasencia, C; Neamati, N; Abad, A 

Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving 

oxaliplatin-based chemotherapy 

INT J CANCER 2009-juny-15; 124 (12): 2905-2910 


IF: 4,722 

Maurel, J; Lopez-Pousa, A; de las Penas, R; Fra, J; Martin, J; Cruz, J; Casado, A; Poveda, A; Martinez-Trufero, J; Balana, C; Gomez, 

MA; Cubedo, R; Gallego, O; Rubio-Viqueira, B; Rubio, J; Andres, R; Sevilla, I; de la Cruz, JJ; del Muro, XG; Buesa, JM Efficacy of 

Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft 

Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas 

J CLIN ONCOL 2009-APR 10; 27 (11): 1893-1898 

IF: 17,793 

Mellado, B; Font, A; Alcaraz, A; Aparicio, LA; Veiga, FJG; Areal, J; Gallardo, E; Hannaoui, N; Lorenzo, JRM; Sousa, A; Fernandez, PL; 

Gascon, P 

Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer 

BRIT J CANCER 2009 oct-13;101:1248-1252 

IF: 4,346 

Millares, L; Rodriguez, N; Andreo, F; Sanz, J; Ramirez, JL; Lopez-Lisbona, R; Seto, L; Taron, M; Rosell, R; Monso, E; Rosell, A 

Aberrant promoter methylation in sputum and bronchial washing in patients at risk for lung cancer 


IF: 4,547 

Mohammed, S; Syro, LV; Scheithauer, BW; Abad, A; Uribe, H; Rotondo, F; Horvath, E; Cusimano, M; Kovacs, K 

Pituitary Adenoma with Peliosis: A Report of Two Cases 

ENDOCR PATHOL 2009; 20:41-45 

IF: 1,417 

Moreno M, Sancho JM, Gardella S, Coll R, García O, Gallardo D, Ribera JM. 

Doxorubicina liposomal no pegilada en combinación con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de 

linfomas no hodgkinianos: estudio de 26 pacientes. 

MED CLIN-BARCELONA 2009; Nov 11 

IF: 1,231 

Motlló C, Xicoy B, Sancho JM, Ribera JM. 

Infiltación cutánea masiva seguida de infiltración del sistema nervioso central en un paciente con leucemia mielomonocítica 

crónica. 

MED CLIN-BARCELONA 2009; JULIO 

IF: 1,231 

Novello, S; Scagliotti, GV; Rosell, R; Socinski, MA; Brahmer, J; Atkins, J; Pallares, C; Burgess, R; Tye, L; Selaru, P; Wang, E; Chao, R; 

Govindan, R 

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer 

BRIT J CANCER 2009; 101:1543-1548 

IF: 4,346 

P Balsalobre, JL Diez-Martin, A Re, M Michieli, JM Ribera, C Canals, A Rosselet, E Conde, R Varela, K Cwynarski, I Gabriel,P Genet, 

G Guillerm, B Allione, A Ferrant, P Biron, I Espigado, D Serrano, A Sureda. 

The European experience on Autologous Stem Cell Transplantation in HIV-related lymphoma patients: An EBMT Lymphoma 

Working Party analysis. 

J CLIN ONCOL 2009; 27: 2192-2198. 

IF: 17,793 

P Miralles, J Berenguer, JM Ribera. 

El diagnóstico, la profilaxis y el tratamiento de sistema nervioso central por el linfoma no Hodgkin en pacientes infectados por VIH 

MED CLIN-BARCELONA 2009; Jul 21 

IF: 1,231 

Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de las Heras N, 

Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín 

A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de 

la Terapéutica en Hemopatías Malignas) Cooperative Study Groups. 

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic 


subgroup of symptomatic multiple myeloma patients. 

BLOOD 2009;114(20):4369-72 

IF: 10,555 

Provencio, M; Camps, C; Alberola, V; Massutti, B; Vinolas, N; Isla, D; Domine, M; Millan, I; Cobo, M; Rosell, R 

Lung cancer and treatment in elderly patients: The Achilles Study 

LUNG CANCER 2009; 66:103-106 

IF: 3,140 

Provencio, M; Sanchez, A; Gasent, J; Gomez, P; Rosell, R 

Cancer Treatments: Can We Find Treasures at the Bottom of the Sea 

CLIN LUNG CANCER 2009; 10:295-300 

IF: 1,509 

Reguart, N; Isla, D; Cardenal, F; Cardona, A; Palmero, R; Moran, T; Rolfo, CD; Nadal, ES; Massuti, T; Montanes, A; Queralt, C; 

Taron, M; Rosell, R 

Phase I trial of vorinostat in combination with erlotinib for advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR 

mutations after erlotinib progression 


IF: 4,547 

Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Ferrándiz C 

Management of primary cutaneous Melanoma of the hands and feet: a clinicoprognostic study 

DERMATOL SURG 2009; 35(10):1505-13.(A) 

IF: 2,343 

Ribera JM, Oriol A, Sancho JM, Morgades M, García O, Ferrá C, Xicoy B, Batlle M, Flores A, Vives S, Jiménez MJ, Juncà J, 

Granada I, Zamora L, Millá F, Feliu E. 

Tratamiento de la leucemia aguda linfoblástica del adulto. 

HAEMATOL-HEMATOL J 2009; 94 (extr 1): 39-50 

IF: 6,416 

Rodríguez I, Grau J, Sancho JM, Ribera JM. 

Síndrome hemofagocítico asociado a linfoma B difuso de célula grande. 

MED CLIN-BARCELONA 2009; DEC 

IF: 1,231 

Rosell, R; Moran, T 

CLINICAL TRIALS BASED ON BIOMARKERS 

LUNG CANCER 2009-MAY; 64: S4-S4 

IF: 3,140 

Rosinol, L; Cibeira, MT; Martinez, J; Mateos, MV; Terol, MJ; de la Rubia, J; Palomera, L; de Arriba, F; Oriol, A; Amor, AA; Besalduch, 

J; de Paz, R; Garcia-Larana, J; Diaz-Mediavilla, J; Sureda, A; Lahuerta, JJ; San Miguel, J; Blade, J 

Thalidomide/Dexamethasone (TD) Versus Bortezomib (Velcade)/Thalidomide/Dexamethasone (VTD) Versus VB 

CLIN LYMPHOMA MYELOM 2009-FEB; 9 : S26-S26 

IF: 1,130 

Safont, MJ; Artal-Cortes, A; Sirera, R; Gomez-Codina, J; Gonzalez-Larriba, JL; Barneto, I; Carrato, A; Isla, D; Rosell, R; Camps, C 

Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatinbased 

combinations in patients with small-cell lung cancer 

LUNG CANCER 2009-JAN; 63 (1): 83-87 

IF: 3,140 

Sanchez-Wandelmer, J; Hernandez-Pinto, AM; Cano, S; Davalos, A; de la Pena, G; Puebla-Jimenez, L; Arilla-Ferreiro, E; Lasuncion, 

MA; Busto, R 

Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells 

J NEUROCHEM 2009; 110:631-640 

IF: 3,999 

Sastre, J; Aranda, E; Massuti, B; Tabernero, J; Chaves, M; Abad, A; Carrato, A; Reina, JJ; Queralt, B; Gomez-Espana, A; Gonzalez- 

Flores, E; Rivera, F; Losa, F; Garcia, T; Sanchez-Rovira, P; Maestu, I; Diaz-Rubio, E 


Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy 

with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study 

CRIT REV ONCOL HEMAT 2009-MAY; 70 (2): 134-144 

IF: 5,269 

Sola M, Fraile M, Mariscal A, Julian FJ, Gubern JM, Culell P, Puig P, Peñalva G, Deulofeu P, Janer J, Valles A, Encinas X, Calvo E, 

Vallejos V, Mila M. 

Estudio comparativo de la técnica del ganglio centinela entre los casos de carcinoma de mama multifocal y unifocal. 

Radiologia 2009;51:140-7 

Sola M, Recaj M, Calvo E, Sune J, Robles J, Puig P, Fraile M 

En Garde, Sentinel Node! 

REV ESP MED NUCL 2009-SEP-OCT; 28 (5): 246-248 

IF: 0,765 

Sola M., Recaj M., Calvo E., Sune J., Robles J., Puig P., Fraile M. 

Inverted exclamation markEn guardia, centinela! 

REV ESP MED NUCL 2009 Sep-Oct;28(5):246-8. Epub 2009 Jul 28. 

IF: 0,765 

Suarez, MS; Andres, RP; de Pablo, PP; Collsamata, PC; Bota, EC; Arroyo, VV; Fraile M 

Utility of bone SPECT-CT in percutaneous vertebroplasty 

REV ESP MED NUCL 2009 NOV-DEC;28:291-294 

IF: 0,765 

Vilanova, JC; Comet, J; Barcelo-Vidal, C; Barcelo, J; Lopez-Bonet, E; Maroto, A; Arzoz, M; Moreno, A; Areal, J 

Peripheral Zone Prostate Cancer in Patients with Elevated PSA Levels and Low Free-to-Total PSA Ratio: Detection with MR Imaging 

and MR Spectroscopy 

RADIOLOGY 2009 OCT;253:135-143 

IF: 6,341 

Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socié G, Rio B, Sirvent A, Renaud M, Madero L, Mohty M, Ferra C, Garnier 

F, Loiseau P, Garcia J, Lecchi L, Kögler G, Beguin Y, Navarrete C, Devos T, Ionescu I, Boudjedir K, Herr AL, Gluckman E, Rocha V 

Eurocord-Netcord and Acute Leukaemia Working Party of the EBMT. KIR-ligand incompatibility in the graft-versus-host direction 

improves outcomes after umbilical cord blood transplantation for acute leukemia. 

LEUKEMIA 2009; 23(3):630. 

IF: 8,296 

Willemze, R; Rodrigues, CA; Labopin, M; Sanz, G; Michel, G; Socie, G; Rio, B; Sirvent, A; Renaud, M; Madero, L; Mohty, M; Ferra, C; 

Garnier, F; Loiseau, P; Garcia, J; Lecchi, L; Kogler, G; Beguin, Y; Navarrete, C; Devos, T; Ionescu, I; Boudjedir, K; Herr, AL; Gluckman, 

E; Rocha, V 

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for 

acute leukemia 

LEUKEMIA 2009-MAR; 23 (3): 492-500 

IF: 8,296 

Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, Valencia ME, Abella E, López-Guillermo A, Sureda A, Morgades M, 

Navarro JT, Esteban H. 

Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related 

Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen. 

LEUKEMIA LYMPHOMA 2009; 50: 1718-20 

IF: 2,397 


Balague O, Mozos A, Martinez D, Hernandez L, Colomo L, Mate JL, Teruya-Feldstein J, Lin O, Campo E, Lopez-Guillermo A, 

Martinez A. 

Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of 

normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications. 

AM J PATHOL 2009 Jun;174(6):2337-46. Epub 2009 Apr 23. 


IF: 5,673 

Barba, I; Sanz, C; Barbera, A; Tapia, G; Mate, JL; Garcia-Dorado, D; Ribera, JM; Oriol, A 

Metabolic fingerprinting of fresh lymphoma samples used to discriminate between follicular and diffuse large B-cell lymphomas 

EXP HEMATOL 2009 NOV;37:1259-1265 

IF: 3,106 

Bartolucci, R; Wei, J; Sanchez, JJ; Perez-Roca, L; Chaib, I; Puma, F; Farabi, R; Mendez, P; Roila, F; Okamoto, T; Taron, M; Rosell, R 

XPG mRNA Expression Levels Modulate Prognosis in Resected Non-Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 

Expression 

CLIN LUNG CANCER 2009-JAN; 10 (1): 47-52 

IF: 1,509 

Boix, R; Sanz, C; Mora, M; Quer, A; Beyer, K; Musulen, E; Gonzalez, C; Bayona, S; Saladie, JM; Ariza, A 

Primary Renal Cell Carcinoma in a Transplanted Kidney: Genetic Evidence of Recipient Origin 

TRANSPLANTATION 2009-APR 15; 87 (7): 1057-1061 

IF: 3,498 

Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cavé 

H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, 

Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ. 

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment 

in Kiel, Germany, 18-20 September 2008. 

LEUKEMIA 2009; doi:10.1038/leu.2009.268. 

IF: 8,296 

D Gallardo, R Cámara, JB Nieto, I Espigado, A Iriondo, A Jiménez-Velasco, C Vallejo, C Martin, D Caballero, S Brunet, D Serrano, C 

Solano, JM Ribera, J de la Rubia, E Carreras. 

Is mobilized peripheral blood stem cells comparable with bone marrow as a source of hematopoietic cells for allogeneic 

transplantation from HLA-identical sibling donors. A case – control study. 

HAEMATOL-HEMATOL J 2009; 94:1282-8 

IF: 6,416 

Danesi, R; Altavilla, G; Giovannetti, E; Rosell, R 

Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors 

PHARMACOGENOMICS 2009-JAN; 10 (1): 69-80 

IF: 3,991 

Danesi, R; Pasqualetti, G; Giovannetti, E; Crea, F; Altavilla, G; Del Tacca, M; Rosell, R 

Pharmacogenomics in non-small-cell lung cancer chemotherapy 

ADV DRUG DELIVER REV 2009-MAY 20; 61 (5): 408-417 

IF: 11,957 

Giros A, Grzybowski M, Sohn VR, Pons E, Fernandez-Morales J, Xicola RM, Sethi P, Grzybowski J, Goel A, Boland CR, Gassull MA, 

Llor X. 

Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. 

CANCER PREV RES 2009 Aug;2(8):732-42. Epub 2009 Jul 28. 

IF: 4,678 

Hilari JM, Mangas C, Xi L, Paradelo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE. 

Molecular Staging of Pathologically Negative Sentinel Lymph Nodes from Melanoma Patients Using Multimarker, Quantitative 

Real-Time RT-PCR. 

ANN SURG ONCOL 2009 Jan;16(1):177-85. Epub 2008 Nov 4 

IF: 4,130 

Isla, D; Cobo, M; Ramirez, JL; Sanchez-Ronco, M; de Aguirre, I; Provencio, M; Lopez-Vivanco, G; Camps, C; Domine, M; Alberola, V; 

Taron, M; Rosell, R 

Blood-based CHRNA3 single nucleotide polymorphisms (SNPs) and outcome in advanced non-small-cell lung cancer (NSCLC) 

patients 


IF: 4,547 


Martinez-Balibrea, E; Plasencia, C; Gines, A; Martinez-Cardus, A; Musulen, E; Aguilera, R; Manzano, JL; Neamati, N; Abad,A 

A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer 

and in human cell lines 

MOL CANCER THER 2009-APR; 8 (4): 771-778 

IF: 4,953 

Martinez-Cardus, A; Martinez-Balibrea, E; Bandres, E; Malumbres, R; Gines, A; Manzano, JL; Taron, M; Garcia-Foncillas, J; Abad, A 

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer 

MOL CANCER THER 2009-JAN; 8 (1): 194-202 

IF: 4,953 

Massuti, B; Cobo, M; Sanchez, JM; Rodriguez-Paniagua, JM; Jimenez, U; Aguiar, D; Arrabal, R; Gonzalez-Larriba, JL; Reguart, N; 

Astudillo, J; Taron, M; Rosell, R 

The pharmacogenomic approach in adjuvant setting of NSCLC: postoperative chemotherapy customized according BRCA1 levels; 

docetaxel single agent arm compared with platinum doublets; SCAT pilot trial results 


IF: 4,547 

Moran, T; Mayo, C; Queralt, C; Molina, MA; Benlloch, S; Quiroga, V; Rolfo, C; Cuello, M; Carcereny, E; Cardona, AF; Taron, M; 

Rosell, R 

Mutations of EGFR (mEGFR) in tumor tissue and serum DNA from stage IV non-small-cell lung cancer (NSCLC) patients (p) 

prospectively treated with erlotinib 


IF: 4,547 

Musulen, E; Sanz, C; Benito, L; Ariza, A 

Screening for lynch syndrome in a series of 869 colorectal carcinomas 

VIRCHOWS ARCH 2009-AUG; 455: 87-88 

IF: 2,305 

Pérez-García A, Brunet S, Berlanga JJ, Tormo M, Nomdedeu J, Guardia R, Ribera JM, Heras I, Llorente A, Hoyos M, Esteve J, 

Besalduch J, Bueno J, Sierra J, Gallardo D; Grupo cooperativo para el estudio y tratamiento de las leucemias agudas. 

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction 

chemotherapy. 

LEUKEMIA 2009 Mar;23(3):486-91. Epub 2008 Dec 18 

IF: 8,296 

Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-Vence N, González- 

Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A; Spanish 

Group for the Study of CNS Disease in NHL. 

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. 

J CLIN ONCOL 2009 Mar 20;27(9):1462-9. Epub 2009 Feb 17. 

IF: 17,793 

Rosell R, Bertran-Alamillo J, Molina MA, Taron M. 

IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory 

hepatocellular tumors. 

FUTURE ONCOL 2009 Apr;5(3):305-8. 

Rosell R, Perez-Roca L, Sanchez JJ, Cobo M, Moran T, Chaib I, Provencio M, Domine M, Sala MA, Jimenez U, Diz P, Barneto I, 

Macias JA, de Las Peñas R, Catot S, Isla D, Sanchez JM, Ibeas R, Lopez-Vivanco G, Oramas J, Mendez P, Reguart N, Blanco R, Taron 

M. 

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression. 

PLOS ONE 2009;4(5):e5133. Epub 2009 May 5. 

IF: 4,351 

Rosell, R 

Pharmacogenomic approaches 


IF: 4,547 

Wei, J; Okamoto, T; Sanchez-Ronco, M; Chaib, I; Perez-Roca, L; Mendez, P; Taron, M; Liu, BR; Rosell, R 


Bio-ANITA project: increased BRCA1 mRNA levels predict favorable outcome in non-small cell lung cancer (NSCLC) patients 

receiving adjuvant cisplatin (cis)/vinorelbine (vrb) 


IF: 4,547 

Projectes 


MORERA PRAT, JOSEP - PNEUMOLOGIA 


Estudio de la vía de señalización de la prostaglandina E2 en cáncer de pulmón y su relación con en receptor del factor de 

crecimiento epidérmico. 

Durada: 2 anys - (2009-2011) 


ROSELL COSTA, RAFAEL - ONCOLOGIA MÈDICA 

National Cancer Institut - Núm. Exp.: 1 U01 CA114771 

Firmas moleculares en cáncer de pulmon. 

Durada: 4 anys - (2006-2010) 



ANDREO GARCIA, FELIPE CRISTOBAL - PNEUMOLOGIA 

SOCAP - Núm. Exp.: 

Rentabilitat diagnòstica de la ultrasonografia endobronquial en el diagnòstic i estadificació de carcinoma de pulmó no cèl·lula 

petita. 

Durada: 3 anys - (2008-2011) 


BALAÑA QUINTERO, CARMEN - ONCOLOGIA MÈDICA 

FIS - Núm. Exp.: EC08/00071 

Estudio abierto, fase II aleatorizado de tratamiento neo-adyuvante con 3 ciclos de temozolamida a dosis extendidas, previos al 

tratamiento con temozolamida más irradiación, versus mismo tratamiento con bevacizumab bisemanal en pacientes con 

Glioblastoma clase V-VI de la RPA EORTC y sólo biopsia. 

Durada: 3 anys - (2008-2011) 



FIS - Núm. Exp.: PS09/01612 

Estadificación nodal sistemática con ultrasonografía endobronquial lineal en el carcinoma pulmonar no microcítico 

Durada: 3 anys - (2009-2012) 


SERRANO MAESTRO, ALFONS - HEMATOLOGIA I HEMOTERÀPIA 

Fundación Española de Hematología y Hemoterapia - Núm. Exp.: 

Análisis de los eventos a largo plazo relacionados con el tratamiento en pacientes adultos con leucemia aguda linfoblástica en 

remisión completa y su comparación con la población general. 

Durada: 1 anys - (2009-2010) 


TEIXIDOR RODRIGUEZ, Ma. DEL PILAR - NEUROCIRURGIA 

Ministerio de Sanidad y Politica Social - Núm. Exp.: TRA-085 

Estudio observacional multicéntrico de seguimiento de una cohorte de pacientes con glioma de alto grado con resección 

quirúrgica guiada con ácido 5-aminolevulínico. 

Durada: 2 anys - (2009-2011) 




ABAD ESTEVE, ALBERT - ONCOLOGIA MÈDICA 


Polimorfismos genéticos (Opmr-1, βarrestina 2, stat6 y COMT) y su influencia en la tolerancia al tratamiento con opiáceos 

mayores.Papel en la selección de rotación individualizada de opiáceos. 

Durada: 3 anys - (2007-2010) 


FELIU FRASNEDO, EVARIST - HEMATOLOGIA I HEMOTERÀPIA 


Estudio de los perfiles de expresión génica en síndromes mielodisplásicos que ayuden a identificar subgrupos pronósticos y 

morfológicos. 

Durada: 4 anys - (2005-2009) 


MARTINEZ BALIBREA, EVA - ONCOLOGIA MÈDICA 

FIS - Núm. Exp.: PS09/01334 

Estudio de la expresión de genes relacionados con resistencia a quimioterapia basada en oxaliplatino en líneas celulares y tejido 

de pacientes con cáncer colorrectal avanzado 

Durada: 3 anys - (2009-2012) 



FUCAP - Núm. Exp.: Beca Oscar Ravà 

Detección de displasia bronquial y carcinoma in situ a nivel molecular y endoscópico en una población de riesgo de cáncer de 

pulmón por enfermedad pulmonar obstructiva crónica (EPOC). 

Durada: 3 anys - (2009-2012) 


ROSELL COSTA, RAFAEL - ONCOLOGIA MÈDICA 


Análisis de expresión génica en pacientes con carcinoma broncopulmonar no microcítico en estadios quirúrgicos y su papel en la 

predicción de metástasis. 

Durada: 4 anys - (2005-2009) 


SALA LLINÀS, MARGARITA - APARELL DIGESTIU 

FIS - Núm. Exp.: PS09/00751 

Identificación de marcadores diagnóstico y pronóstico en plasma de cáncer hepático mediante análisis proteómico. 

Durada: 3 anys - (2009-2012) 



EPIDEMIOLOGIA CLÍNICA 

Y MOLECULAR 

SALUD PÚBLICA. 

SALUD INTERNACIONAL 

Publicacions 


Cueto, R; Lucena, MI; Crespo, E; Ulzurrun, E; Ruiz-Cabello, F; Borraz, Y; Cabello, M; Fernandez, M; Madrazo, A; Romero-Gomez, M; 

Costa, J; Barriocanal, A; Planas, R; Salmeron, JF; Soriano, G; Andrade, R 

Frequency of-24 c > t polymorphism in the hepatic canalicular transporter abcc2 gene in spanish population basic 

CLIN PHARMACOL 2009-AUG; 105: 78-79 

IF: 2,308 

Esteve A, Fortiana J, Boj E 

Interaction terms in distance-based regresion 

COMMUN STAT-THEOR M 2009; 38:1-12 

IF: 0,406 

Gómez-Díaz E, González-Solís J, Peinado MA. 

Population structure in a highly pelagic seabird, the Cory’s shearwater (Calonectris diomedea): an examination of genetics, 

morphology and ecology. Marine Ecology Progress Series, 

MAR ECOL-PROG SER 2009; 382:197-209 

IF: 2,519 

Jordà M, Peinado MA. 

Gene regulation of the social behavior in the honey bee (in Spanish). 

Investigación y Ciencia 2009; 395:40-43 


Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, 

Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, 

Saag M. 

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS defining 

conditions are created equal. 

CLIN INFECT DIS 2009 Apr 15;48(8):1138-51. 

IF: 8,195 

Bielsa I, Soria X, Esteve M, Ferrándiz C; on behalf of the Skin Cancer Study Group of Barcelonès Nord 

Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. 

BRIT J DERMATOL 2009;161:1341-1346 (A) 

IF: 4,260 

Brown AE, Gifford RJ, Clewley JP, Kucherer C, Masquelier B, Porter K, Balotta C, Back NK, Jorgensen LB, de Mendoza C, Bhaskaran 

K, Gill ON, Johnson AM, Pillay D; Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration. 

Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous 

epidemiological definitions. 

J INFECT DIS 2009 Feb 1;199(3):427-31. 

IF: 5,865 

Butler LM, Dorsey G, Hladik W, Rosenthal PJ, Brander C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard 


SC, Martin JN. 

Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidencefor at 

least 2 patterns of KSHV transmission. 

J INFECT DIS 2009:430-438. 

IF: 5,865 

Calmet, M; Juve, R; Alberny, M; Andreu, A; Loureiro, E; Matas, L; Vilamala, A; Casabona, J 

Diagnostic resources for sexually-transmitted infections in laboratories in Catalonia (Spain) 

GACETA SANITARIA 2009-JUL-AUG; 23 (4): 348-350 

Caro-Murillo, AM; Gutierrez, F; Ramos, JM; Sobrino, P; Miro, JM; Lopez-Cortes, LF; Tural, C; Moreno, A; Gil, ID; Angoiti, JM; 

Camino, X; Lleti, MS; Rubio, R; Moreno, S; del Amo, J 

HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006) 

ENFERM INFEC MICR CL 2009-AUG-SEP; 27 (7): 380-388 

IF: 1,393 

Del Pino-Montes J et al y grupo de trabajo del registro 

Caracterísitcas de la enfermedad ósea de Paget en España. Datos del Registro Nacional de Paget. 

Reumatología Clínica 2009; 5: 109-114. 

Esteve M, Casas I, Clèries R, Ribes J. 

Diagnostico de cancer en trabajadores de un centro sanitario. 

MED CLIN-BARCELONA 2009; 133(2):53-6. 

IF: 1,231 

Fernàndez L, Rifà B, Pujol F, Becerra J, Pérez M, Merono M, Zaragoza,K, Rafael A, Diaz O, Avellaneda A, Casado, MJ, Giménez A, 

Casabona J 

Impact of the introduction of rapid HIV testing in the Voluntary Counseling and Testing sites network of Catalonia, Spain 

INT J STD AIDS 2009; [Epub ahead of print] 

IF: 1,050 

Folch C, Esteve A, Zaragoza K, Muñoz R, Casabona J. 

Correlates of intensive alcohol and drug use in men who have sex with men in Catalonia, Spain. 

EUR J PUBLIC HEALTH 2009 Jun 29. [Epub ahead of print] 

IF: 2,313 

Folch C, Munoz R, Zaragoza K, Casabona J. 

Sexual risk behaviour and its determinants among men who have sex with men in Catalonia, Spain. 

Euro Surveill 2009 Nov 26;14(47). pii: 19415. 

Folch C., Esteve A., Sanclemente C., Martró E., Lugo R., Molinos S., Gonzalez V., Ausina V., Casabona J. (CIBERESP) 

Diferencias en las características sociales, conductas de riesgo y prevalencia de VIH/infecciones de transmisión sexual 

entre trabajadoras del sexo españolas e inmigrantes en Cataluña. 

MED CLIN-BARCELONA 2009; 132: 385-388 

IF: 1,231 

Folch, C; Sanclemente, C; Esteve, A; Martro, E; Molinos, S; Casabona, J 

Social characteristics, risk behaviours and differences in the prevalence of HIV/sexually transmitted infections between Spanish 

and inmigrant female sex workers in Catalonia, Spain 

MED CLIN-BARCELONA 2009-març-21; 132 (10): 385-388 

IF: 1,231 

Gadelha, T; Bisbe, J; Toril, J; Pedrajas, JNA; Monreal, M 

Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA 

registry(1) 

J THROMB HAEMOST 2009-AUG; 7 (8): 1414-1416 

IF: 6,069 

Garcia M, Morillas RM, Miquel M, Rodriguez O, Cirera I, Vergara M, Sala M, Gimenez MD, Cañete N, Gallach M, Ardèvol M, 

Alvarez MA, Montoliu S, Romero M, Planas R, Solá R. 

Predictive factors of sustained virological response in patients with complete early virological response to the treatment of 

hepatitis 


HEPATOLOGY 2009, 50(supll):A875 

IF: 10,840 

Garrido, P; Majen, M; Vinolas, N; Artal, A; Isla, D; Felip, E; De Castro, J; Terrasa, J; Garcia-Campelo, R; Bover, I; Amador, ML; Rosell, 

R 

Lung cancer in women: the Spanish female-specific database WORLD 07 


IF: 4,547 

Gomez, M; Valle, V; Aros, F; Sanz, G; Sala, J; Fiol, M; Bruguera, J; Elosua, R; Molina, L; Marti, H; Covas, MI; Rodriguez-Llorian, A; 

Fito, M; Suarez-Pinilla, MA; Amezaga, R; Marrugat, J 

Oxidized LDL, Lipoprotein (a) and Other Emergent Risk Factors in Acute Myocardial Infarction (FORTIAM study) 

REV ESP CARDIOL 2009-APR; 62 (4): 373-382 

IF: 2,746 

Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, Swedberg K, Pfeffer MA, McMurray JJ, Maggioni AP; 

Valsartan in Acute Myocardial Infarction Trial Investigators. (Valle, Lupón) 

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with 

myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). 

EUR J HEART FAIL 2009 Mar;11(3):292-8. Epub 2009 Jan 27. 

IF: 3,706 

Huntington S, Folch C, González V, Meroño M, Ncube F, Casabona J. 

Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in 

Catalonia. 

ENFERM INFEC MICR CL 2009 Aug 18. [Epub ahead of print] 

IF: 1,393 

Jordan AJ, Amguita MP, Investigafores BADAPIC (Lupón) 

Efecto del tratamiento con estatinas en la mortalidad de una gran cohorte de pacientes con insuficiencia cardiaca 

REV ESP CARDIOL 2009; 62:323-7. 

IF: 2,746 

Levy WC, Mozaffarian D, Linker DT, et al. COMET Investigators (Valle, Lupón) 

Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. 

EUR J HEART FAIL 2009; 11:256-63 

IF: 3,706 

Mirandola M, Folch Toda C, Krampac I, Nita I, Stanekova D, Stehlikova D, Toskin I, Gios L, Foschia JP, Breveglieri M, Furegato M, 

Castellani E, Bonavina MG; SIALON network. 

HIV bio-behavioural survey among men who have sex with men in Barcelona, Bratislava, Bucharest, Ljubljana, Prague and Verona, 

2008-2009. 

Euro Surveill 2009; 14(48). pii: 19427. 

Monreal, M; Trujillo-Santos, J 

Lessons from VTE registries: the RIETE experience 

BEST PRACT RES CL HA 2009-MAR; 22 (1): 25-33 

IF: 3,134 

Mothe, B; Perez, I; Domingo, P; Podzamczer, D; Ribera, E; Curran, A; Vilades, C; Vidal, F; Dalmau, D; Pedrol, E; Negredo, E; Molto, 

J; Paredes, R; Perez-Alvarez, N; Gatell, JM; Clotet, B 

HIV-1 Infection in Subjects Older than 70: A Multicenter Cross-Sectional Assessment in Catalonia, Spain 

CURR HIV RES 2009; 7:597-600 

IF: 1,978 

Pérez Cachafeiro S, Del Amo J, Iribarren JA, Salavert Lleti M, Gutiérrez F, Moreno A, Labarga P, Pineda JA, Vidal F, Berenguer J, 

Moreno S; Cohorts of the Spanish AIDS Research Network (CoRIS and CoRIS-MD). 

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006. 

CLIN INFECT DIS 2009 May 15;48(10):1467-70 

IF: 8,195 

Qamar, AA; Grace, ND; Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Burroughs, AK; Ripoll, C; Maurer, R; Planas, R; Escorsell, A; Garcia- 


Pagan, JC; Patch, D; Maltoff, DS; Makuch, R; Rendon, G 

Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis 

CLIN GASTROENTEROL H 2009-JUN; 7 (6): 689-695 

IF: 5,642 

Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, Meacci M, Meccugni B, 

Rumpianesi F, Roversi P, Cerri S, Luppi F, Ferrara G, Latorre I, Gerunda GE, Torelli G, Esposito R, Fabbri LM. 

Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 

CHEST 2009 Jul;136(1):198-204. Epub 2009 Mar 24. 

IF: 6,360 

Rios, E; Ferrer, L; Casabona, J; Cayla, J; Avecilla, A; Prat, JGI; Edison, J; Perez, O; Garcia, S; Toran, P; Ruiz, M; Gros, T; Rodriguez, L; 

Arribas, D; Folch, C; Esteve, A 

Knowledge of HIV and sexually-transmitted diseases in Latin American and Maghrebi immigrants in Catalonia (Spain) 

GACETA SANITARIA 2009 NOV-DEC;23:533-538 

Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña 

C, Llanos AC, Cantón R, Pascual A. 

Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. 

J ANTIMICROB CHEMOTH 2009; 63(4):781-4. 

IF: 4,352 

Romero, A; Gonzalez, V; Granell, M; Matas, L; Esteve, A; Martro, E; Rodrigo, I; Pumarola, T; Miro, JM; Casanova, A; Ferrer, E; Tural, 

C; del Romero, J; Rodriguez, C; Caballero, E; Ribera, E; Casabona, J 

Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV 

seroconversion 

SEX TRANSM INFECT 2009-APR; 85 (2): 106-110 

IF: 2,175 

Sabido, M; Giardina, F; Hernandez, G; Fernandez, VH; Monzon, JE; Ortiz, R; Montoliu, A; Casabona, J 

The UALE Project: Decline in the Incidence of HIV and Sexually Transmitted Infections and Increase in the Use of 

Condoms Among Sex Workers in Guatemala 

JAIDS-J ACQ IMM DEF 2009-MAY 1; 51: S35-S41 

IF: 4,207 

Sobrino-Vegas, P; Miguel, LGS; Caro-Murillo, AM; Miro, JM; Viciana, P; Tural, C; Saumoy, M; Santos, I; Sola, J; del Amo, J; 

Moreno, S 

Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on 

Mortality 

CURR HIV RES 2009-MAR; 7 (2): 224-230 

IF: 1,978 

Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, Kaldor J, Folch C, Op de Coul E, Marcus U, Hughes G, 

Archibald CP, Cazein F, McDonald A, Casabona J, van Sighem A, Fenton KA; Annecy MSM Epidemiology Study Group. 

Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996- 

2005. 

ANN EPIDEMIOL 2009 Jun;19(6):423-31 

IF: 2,947 

Suriñach JM, Alvarez LR, Coll R, Carmona JA, Sanclemente C, Aguilar E, Monreal M; FRENA Investigators. 

Differences in cardiovascular mortality in smokers, past-smokers and non-smokers: findings from the FRENA registry. 

EUR J INTERN MED 2009 Sep;20(5):522-6. Epub 2009 Jun 12.PMID: 

IF: 1,385 

The Antiretroviral Therapy (ART) Cohort Collaboration 

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies 

LANCET 2009 Apr 18;373(9672):1352-63 

IF: 30,758 

Urrutia A, Santesmases J, Altimir S, Rey-Joly C. 

Outcome prediction in patients in acute geriatric units 

Rev Esp Geriatr Gerontol 2009; NOV 


Vallès X, Murga GB, Hernández G, Sabidó M, Chuy A, Lloveras B, Alameda F, de San José S, Bosch FX, Pedroza I, Castellsagué X, 

Casabona J. 

High prevalence of human papillomavirus infection in the female population of Guatemala. 

INT J CANCER 2009 Mar 19;125(5):1161-1167. [Epub ahead of print] 

IF: 4,722 

van Veldhuisen DJ, Cohen-Solal A, et al. SENIORS Investigators (Valle, Lupón) 

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data 

From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors 

With Heart Failure). 

J AM COLL CARDIOL 2009; 53:2150-8. 

IF: 12,535 

Vercauteren, J; Wensing, AMJ; van de Vijver, DAMC; Albert, J; Balotta, C; Hamouda, O; Kucherer, C; Struck, D; Schmit, JC; Asjo, B; 

Bruckova, M; Camacho, RJ; Clotet, B; Coughlan, S; Grossman, Z; Horban, A; Korn, K; Kostrikis, L; Nielsen, C; Paraskevis, D; Poljak, 

M; Puchhammer-Stockl, E; Riva, C; Ruiz, L; Salminen, M; Schuurman, R; Sonnerborg, A; Stanekova, D; Stanojevic, M; Vandamme, 

AM; Boucher, CABSPREAD Programme 

Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe 

J INFECT DIS 2009 nov-15;200:1503-1508 

IF: 5,865 

Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group. 

Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history 

of cervical pathology. 

JAIDS-J ACQ IMM DEF 2009 Feb 1;50(2):168-75. 

IF: 4,207 

Weller, I; Costagliola, D; Ledergerber, B; Lundgren, J; Chene, G; Touloumi, G; Warszawski, J; Meyer, L; Dabis, F; Krause, MM; 

Leport, C; de Wolf, F; Reiss, P; Porter, K; Dorrucci, M; Sabin, C; Gibb, D; Del Amo, J; Obel, N; Thorne, C; Mocroft, A; Kirk, O; 

Staszewski, S; Perez-Hoyos, S; Almeda, J; Antinori, A; Monforte, AD; de Martino, M; Brockmeyer, N; Fatkenheuer, G; Ramos, J; 

Battegay, M; Mussini, C; Tookey, P; Casabona, J; Miro, JM; Castagna, A; de Wit, S; Torti, C; Teira, R; Garrido, M; Dedes, N; Sabin, C; 

Phillips, A; Furrer, H; Kirk, O; Egger, M; Dabis, F; Newell, ML; Sterne, J; Telenti, A - The Collaboration of Observational HIV 

Epidemiological Research Europe (COHERE) study group. 

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy 

AIDS 2009; 23:2029-2037 

IF: 4,909 

Zwahlen, M; Harris, R; May, M; Hogg, R; Costagliola, D; de Wolf, F; Gill, J; Fatkenheuer, G; Lewden, C; Saag, M; Staszewski, S; 

Monforte, AD; Casabona, J; Lampe, F; Justice, A; von Wyl, V; Egger, M; Casabona, J; Chene, G; Costagliola, D; Dabis, F; Monforte, 

AD; de Wolf, F; Egger, M; Fatkenheuer, G; Gill, J; Hogg, R; Justice, A; Kitahata, M; Lampe, F; Ledergerber, B; Leport, C; May, M; 

Mocroft, A; Phillips, A; Reiss, P; Saag, M; Sabin, C; Staszewski, S; Sterne, J; Harris, R; Beckthold, B; Yip, B; Dauer, B; Fusco, J; 

Darney, E; Rickenbach, M; Lavignolle, V; van Leth, F; Pereira, E; Pezzotti, P; Phillips, A; Sabin, C 

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine 

industrialized countries 

INT J EPIDEMIOL 2009; 38:1624-1633 

IF: 5,262 


Sabidó M, Hernández G, González V, Vallès X, Montoliu A, Figuerola J, Isern V, Viñado B, Figueroa L, Casabona J. Clinic-based 

evaluation of a rapid point-of-care test for detection of Chlamydia trachomatis in specimens from sex workers in Escuintla, 

Guatemala. J CLIN MICROBIOL 2009 Feb;47(2):475-6. Epub 2008 Dec 3 IF: 4,126 

Projectes 




FIPSE - Núm. Exp.: 32620/06 

Sinergias entre la infección por el VIH y el virus del papiloma humano: historia natural del cáncer de cervix y su prevención en 

mujeres infectadas por el VIH. 

Durada: 3 anys - (2006-2009) 



Ministerio de Trabajo y Asuntos Sociales - Núm. Exp.: 81/06 

Sinergias entre la infección por el VIH y el virus del papiloma humano: historia natural del cáncer de cérvix y su prevención en 

mujeres infectadas por el VIH. (METAS) 

Durada: 2 anys - (2007-2009) 



FIPSE - Núm. Exp.: 36787/08 

Impacto del diagnóstico de VIH en las conductas sexuales. Indicadores, determinantes y evolución temporal en la cohorte PISCIS. 

Durada: 3 anys - (2008-2011) 



AGAUR - Agència de Gestió d'Ajuts Universitaris i de Recerca - Núm. Exp.: 2008ARAF1-00012 

Diagnosi de situació de salut sexual i reproductiva de treballadors/res del sexe immigrants de Catalunya. 

Durada: 2 anys - (2008-2010) 


FOLCH TODA, CINTA - CEEISCAT 

COMISSIÓ EUROPEA - Núm. Exp.: 2008 12 14 EMIS 

European MSM Internet Survey on HIV and STI. (DG Sanco) (EMIS) 

Durada: 3 anys - (2008-2011) 


FOLCH TODA, CINTA - CEEISCAT 


SIALON. Capacity building in HIV and Syphilis prevalence estimation using non invasive methods among msm in countries of south 

and eastern Europe. (DG Sanco) 

Durada: 2 anys - (2007-2009) 


MARTINEZ RIVERA, CARLOS - PNEUMOLOGIA 

FIS - Núm. Exp.: PI08/90251 

AUDIPOC: Auditoría Clínica Nacional sobre exacerbaciones de la EPOC en España. Proyecto Coordinado. Subproyecto AUDIPOC 

Cataluña. 

Durada: 2 anys - (2008-2010) 


MUGA BUSTAMANTE, ROBERT - MEDICINA INTERNA - DESINTOXICACIÓ 


Vacuna preventiva del VIH: Anclaje de una cohorte de individuos a riesgo. Análisis de la aceptación y predisposición a participar 

en un ensayo de vacuna en fase II-III. 

Durada: 3 anys - (2007-2010) 


MUGA BUSTAMANTE, ROBERT - MEDICINA INTERNA - DESINTOXICACIÓ 

FIPSE - Núm. Exp.: 36781/08 

Grupo de estudio multicéntrico español de seroconvertores (GEMES): Estudio del período de incubación del SIDA y la 

supervivencia de la infección por VIH en cohortes de seroconvertores. 

Durada: 3 anys - (2008-2011) 


TURAL LLACHER, CRISTINA - MEDICINA INTERNA - VIH 

FIPSE - Núm. Exp.: 36702/07 

Cohorte de GESIDA de pacientes coinfectados por VIH y virus de Hepatitis C que reciben tratamiento para la Hepatitis C (2008- 


2010). 

Durada: 3 anys - (2007-2010) 



MASIP MASIP, JOAN - CEEISCAT 

FIPSE - Núm. Exp.: 36721/08 

Estudio clínico-epidemiológico de las parejas madre-hijo expuestas al VIH y/o a los fármacos antirretrovirales. 

Durada: 3 anys - (2008-2011) 


SABRIA LEAL, MIQUEL - MEDICINA INTERNA - UMI, MALALTIES INFECCIOSES 


Descripción de factores de virulencia/competencia de L. pneumophila mediante técnicas de proteómica. 

Durada: 3 anys - (2008-2011) 



TECNOLOGÍA APLICADA 

A LA BIOMEDICINA 

(BIOTECNOLOGÍA, 

BIOINGENIERÍA Y BIOINFORMÁTICA) 

Publicacions 


Bogonez-Franco P, Bragos R, Bayes-Genis A, Rosell-Ferrer J. 

Implantable bioimpedance monitor using ZigBee 

Conf Proc IEEE Eng Med Biol Soc 2009;1:4868-71. 

Cañadas MP, Darwich L, Sirera G, Cirigliano V, Bofill M, Clotet B, Videla S; on behalf of the HIV-HPV Study Group. 

New molecular method for the detection of human papillomavirus type 16 integration. 

CLIN MICROBIOL INFEC 2009 Oct 15. [Epub ahead of print] 

IF: 4,014 

Conesa, JA; Font, R; Fullana, A; Martin-Gullon, I; Aracil, I; Galvez, A; Molto, J; Gomez-Rico, MF 

Comparison between emissions from the pyrolysis and combustion of different wastes 

J ANAL APPL PYROL 2009; 84:95-102 

IF: 2,311 

Diestra K., Juan C., Curiao T., Moyá B., Miró E., Oteo J., Coque TM., Pérez-Vázquez M., Campos J., Cantón R., Oliver A., Navarro F., 

and Red Española de Investigación en Patología Infecciosa (REIPI) Spain 

Characterization of plasmids encoding bla ESBL and surrounding genes in Sapnish clinical isolates of Escherichia coli and 

Klebsiella pneumoniae 

J ANTIMICROB CHEMOTH 2009; 63: 60-66 

IF: 4,352 

Fuentes G, Oyarzabal J, Rojas AM. 

Databases of protein-protein interactions and their use in drug discovery. 

CURR OPIN DRUG DISC 2009 May;12(3):358-66. 

IF: 4,904 

JA.Gómez Gerique, F.Izquierdo, A.Galán, P Laporta, N.Garnacho, y Nikos Ekizoglou . 

Evaluación de la Troponina I en el analizador Pathfast. 

REV LAB CLIN 2009;2 :131- 138. ISSN:1888-4008 

Jordà M, Rodríguez J, Frigola J, Peinado MA. 

Analysis of DNA methylation by amplification of intermethylated sites (AIMS). 

Methods Mol Biol 2009;507:107-16. 

Krallinger M, Rojas AM, Valencia A. 

Creating reference datasets for systems biology applications using text mining. 

ANN NY ACAD SCI 2009 Mar;1158:14-28 

IF: 2,670 

Luisa María Villar Guimerans, Juan José Rodríguez Molina, Cándido Juárez Rubio, Grupo de Trabajo de Inmunoquímica (Eva Mª 

Martínez Cáceres) del Taller SEI 2005, y Julia Sequí Navarro 

Análisis interlaboratorio de parámetros inmunoquímicos, paraproteínas y bandas oligoclonales. Informe técnico del IV Taller de 

Inmunoquímica de la Sociedad Española de Inmunología 

Inmunología 2009 Abril-Junio; Vol. 28, Núm 2: 79-95 

Lundin, M; Szymas, J; Linder, E; Beck, H; de Wilde, P; van Krieken, H; Rojo, MG; Moreno, I; Ariza, A; Tuzlali, S; Dervisoglu, S; Helin, 


H; Lehto, VP; Lundin, J 

A European network for virtual microscopy-design, implementation and evaluation of performance 

VIRCHOWS ARCH 2009-APR; 454 (4): 421-429 

IF: 2,305 

Molto, J; Font, R; Galez, A; Conesa, JA 

Pyrolysis and combustion of electronic wastes 

J ANAL APPL PYROL 2009; 84:68-78 

IF: 2,311 

N. Ortega Castillo, J Barallat Martínez de Osaba, Y. Alba Macias, C. Morales Indiano, M Dolade Botias, ML Granada Ybern. 

Estabilidad de las concentraciones de factor de crecimiento similar a la insulina tipo 1, gastrina y androstendiona en suero. 

REV LAB CLIN 2009;2:161-8. ISSN: 1888-4008 

Rosales, M; Radeva, P; Rodriguez-Leor, O; Gil, D 

Modelling of image-catheter motion for 3-D IVUS 

MED IMAGE ANAL 2009-FEB; 13 (1): 91-104 

IF: 3,093 

Zhang, JX; Pilette, MA; Cuevas, F; Charpentier, T; Mauri, F; Latroche, M 

X-ray Diffraction and NMR Studies of Na3-nLinAlH6 (n=0, 1, 2) Alanates Synthesized by High-Pressure Reactive Ball Milling 

J PHYS CHEM C 2009; 113:21242-21252 

IF: 4,224 


Bussadori, C; Moreo, A; Di Donato, M; De Chiara, B; Negura, D; Dall'Aglio, E; Lobiati, E; Chessa, M; Arcidiacono, C; Dua, JS; Mauri, 

F; Carminati, M 

A new 2D-based method for myocardial velocity strain and strain rate quantification in a normal adult and paediatric population: 

assessment of reference values 

Cardiovasc Ultrasound 2009; 7:8 

Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, García-Olivé I, Lacoma A, Ausina V, Domínguez J. 

Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. 

PLOS ONE 2009 Aug 24;4(8):e6686. 

IF: 4,351 

Castano, C; Serena, J; Davalos, A 

Use of the New Solitaire (TM) AB Device for Mechanical Thrombectomy when Merci Clot Retriever Has Failed to Remove the Clot 

A Case Report 

INTERV NEURORADIOL 2009-JUN; 15 (2): 209-214 

IF: 0,128 

Cobo E, Secades JJ, Miras F, Antonio González J, Saver JL, Corchero C, Rius R, Dàvalos A. 

Boosting The Chances To Improve Stroke Treatment 

STROKE 2009 Dec 24. 

IF: 7,041 

Hernández A, Matas L, Ausina V 

Limpieza, desinfección y esterilización en la prevención de las infecciones 

Medicina interna 2009; cap. 254, sección 17 

M.Solá, A.Mariscal, M.Fraile, S.Vizcaya, J.Julián, V.Vallejos, E.Castellà, J. Fuster, M.Milà, 

Radioguided localization of non-palpable breast cáncer lesions. A randomized comparison with wire localization in patients 

undergoing conservative surgery and sentinel node biopsy. 

EUR J NUCL MED MOL I 2009, 36 (suppl 2): S281-S496. 

IF: 4,531 

Mariscal A, Solà M, Pérez A, Julián JF, Fraile M, Vizcaya S, Fernández J. 

Radioguided Localization of Nonpalpable Breast Cancer Lesions: Randomized Comparison With Wire Localization in Patients 

Undergoing Conservative Surgery and Sentinel Node Biopsy. 


AM J ROENTGENOL 2009; 193:1001-1009 

IF: 2,951 

Martro, E; Garcia-Sierra, N; Gonzalez, V; Saludes, V; Matas, L; Ausina, V 

Evaluation of an Automated Nucleic Acid Extractor for Hepatitis C Virus Load Quantification 

J CLIN MICROBIOL 2009-MAR; 47 (3): 811-813 

IF: 4,126 

Navarro JT., Hernández A., Rodríguez-Manzano J., Mate JL., Grau J., Morgades M., Martró E., Tural C., Ribera JM., Matas L. 

Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphola in HIB-infected patients. 

AIDS 2009; accepted 

IF: 4,909 

Plow EB, Carey JR, Nudo RJ, Pascual-Leone A. 

A lnvasive cortical stimulation to promote recovery of function after stroke: a critica1 appraisal. 

STROKE 2009 May;40(5). 

IF: 7,041 

Santos-Garcia, D; Blanco, M; Serena, J; Arias, S; Millan, M; Rodriguez-Yanez, M; Leira, R; Davalos, A; Castillo, J 

Brachial arterial flow mediated dilation in acute ischemic stroke 

EUR J NEUROL 2009-JUN; 16 (6): 684-690 

IF: 2,510 

Tutor-Crespo, MJ; Hermida, J; Romero, R; Tutor, JC 

Two sampling time profiles for the abbreviated estimation of mycophenolic acid area under the curve in adult renal transplant 

recipients treated with mycophenolate mofetil and concomitant tacrolimus 

J CLIN PHARM THER 2009; 34:531-537 

IF: 1,671 


Benito Penalva J, Opisso E, Medina J, Corrons M, Kumru H, Vidal J, Valls-Solé J. 

H reflex modulation by transcranial magnetic stimulation in spinal cord injury subjects affer gait training with electromechanical 

systems 

SPINAL CORD 2009 Nov 24 

IF: 1,783 

Blanco, S; Forne, M; Lacoma, A; Prat, C; Cuesta, MA; Fuenzalida, L; Viver, JM; Dominguez, J 

Evaluation of a latex agglutination test (PYLOGEN) for the detection of Helicobacter pylori in stool specimens 

DIAGN MICR INFEC DIS 2009-APR; 63 (4): 349-353 

IF: 2,451 

Cardona, PJ; Asensio, JG; Arbues, A; Otal, I; Lafoz, C; Gil, O; Caceres, N; Ausina, V; Gicquel, B; Martin, C 

Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant 

VACCINE 2009-APR 21; 27 (18): 2499-2505 

IF: 3,616 

Fuenzalida L, Blanco S, Prat C, Vivancos M, Dominguez MJ, Mòdol JM, Rodrigo C, Ausina V. 

Utility of the rapid antigen detection BinaxNOW A&B test for detection of novel influenza A (H1N1) virus. 

CLIN MICROBIOL INFEC 2009 Dec 29. [Epub ahead of print] 

IF: 4,014 

Garcia-Sierra, N; Martro, E; Castella, E; Llatjos, M; Tarrats, A; Bascunana, E; Diaz, R; Carrasco, M; Sirera, G; Matas, L; Ausina, V 

Evaluation of an Array-Based Method for Human Papillomavirus Detection and Genotyping in Comparison with Conventional 

Methods Used in Cervical Cancer Screening 

J CLIN MICROBIOL 2009-JUL; 47 (7): 2165-2169 

IF: 4,126 

Gatta, C; Pujol, O; Rodriguez-Leor O; Mauri J; Radeva P 

Fast Rigid Registration of Vascular Structures in IVUS Sequences 

IEEE T INF TECHNOL B 2009 NOV;13:1006-1011 


IF: 1,694 

Hernandez-Sabate, A; Gil, D; Fernandez-Nofrerias, E; Radeva, P; Marti, E 

Approaching Artery Rigid Dynamics in IVUS 

IEEE T MED IMAGING 2009 NOV;28:1670-1680 

IF: 3,540 

Jafari, C; Thijsen, S; Sotgiu, G; Goletti, D; Dominguez J; Losi, M; Eberhardt, R; Kirsten, D; Kalsdorf, B; Bossink, A; Latorre, I; Migliori, 

GB; Strassburg, A; Winteroll, S; Greinert, U; Richeldi, L; Ernst, M; Lange, C 

Bronchoalveolar Lavage Enzyme-linked Immunospot for a Rapid Diagnosis of Tuberculosis A Tuberculosis Network European 

Trialsgroup Study 

AM J RESP CRIT CARE 2009-oct-01; 180 (7): 666-673 

IF: 10,689 

Laurencin, D; Gervais, C; Wong, A; Coelho, C; Mauri, F; Massiot, D; Smith, ME; Bonhomme, C 

Implementation of High Resolution Ca-43 Solid State NMR Spectroscopy: Toward the Elucidation of Calcium Sites in Biological 

Materials 

J AM CHEM SOC 2009; 131:13430-13440 

IF: 8,580 

Moreo, A; Ambrosio, G; De Chiara, B; Pu, M; Tran, T; Mauri, F; Raman, SV 

Influence of Myocardial Fibrosis on Left Ventricular Diastolic Function Noninvasive Assessment by Cardiac Magnetic Resonance 

and Echo Circulation-cardiovascular imaging 2009; 2:437-443 

Quesada MD, Giménez M, Molinos S et al 

Performance of VITEK-2 compact and overnight microscan panels for direct identificaction and susceptibility testing of 

gramnegative bacilli from positive FAN BacT/AlerT blood culture bottles 

CLIN MICROBIOL INFEC 2009. 

IF: 4,014 

Projectes 


GASSULL DURO, MIQUEL ANGEL - DIRECCIÓ CIENTÍFICA 

CIDEM - Núm. Exp.: VALCON08-2-0008 

Avaluació de la cartera de projectes de l'IGTP. 

Durada: 1 anys - (2009-2010) 


JULIAN IBAÑEZ, JUAN FRANCISCO - CIRURGIA GENERAL I DIGESTIVA 

CIDEM - Núm. Exp.: VALTEC09-2-0098 

Ús de gel de plaquetes per a la cirurgia restitutiva de volum de la mama (PRP) 

Durada: 2 anys - (2009-2011) 


MAURI FERRE, JOSEPA - CARDIOLOGIA 


Caracterización de la placa mediante análisis por visión artificial a partir de imágenes de ecografía intracoronaria. 

Durada: 3 anys - (2006-2009) 


RODRIGUEZ LEOR, ORIOL - CARDIOLOGIA 


Valoración semicuantitativa de la perfusión miocárdica en el infarto agudo de miocardio a partir del análisis angiográfico. Valor 

pronóstico en pacientes tratados con angioplastia primaria. 

Durada: 3 anys - (2007-2010) 



INNOVACIÓN CLÍNICO- 

TERAPÉUTICA Y 

SERVICIOS SANITARIOS 

Publicacions 


Fernandez-Cancio, M; Audi, L; Carrascosa, A; Toran, N; Andaluz, P; Esteban, C; Granada, ML 

Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal 

epiphyseal chondrocytes 

GROWTH HORM IGF RES 2009-JUN; 19 (3): 232-237 

IF: 2,352 

García-Molina A, Enseñat-Cantallops A, Tirapu-Ustárroz J, Roig-Rovira T. 

Maturation of the prefrontal cortex and development of the executive functions during the first five years of life. 

REV NEUROLOGIA 2009 Apr 16-30; 48(8):435-40. 

IF: 1,234 

Lucena, MI; Crespo, E; Ulzurrun, E; Ruiz-Cabello, F; Borraz, Y; Cueto, R; Robles, M; Fernandez, MC; Romero-Gomez, M; Costa, J; 

Barriocanal, A; Planas, R; Guarner, C; Andrade, RJ 

Role of polymorphic bile salt export pump (bsep, abcb11) and multidrug-resistance-associated protein 2 (mrp2, abcc2) 

transporters in drug-induced liver injury 

BASIC CLIN PHARMACOL 2009-AUG; 105: 76-77 

IF: 2,308 

Ricós C., Perich C., Álvarez V., Biosca C., Doménech MV., Jiménez CV., Minchinela J., Simón M., Cava F., Garcia Lario JV., Fernández 

P. 

Aplicación del modelo Seis-Sigma en la mejora de la calidad analítica del laboratorio clínico 

REV LAB CLIN 2009;2:2-7. 


A.Carreres 

El punt de vista d’una metgessa assistencial d’hospital. 

REV R ACAD MED CATALUNYA 2009; 24: 53-56 

Andreo F, Ruiz-Manzano J, Prat C, Lores L, Blanco S, Malet A, Gallardo X, Domínguez J. 

Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients. 

RESP MED 2009 Nov 4. [Epub ahead of print] 

IF: 2,331 

Andreo, F; Prat, C; Ruiz-Manzano, J; Lores, L; Blanco, S; Cuesta, MA; Gimenez, M; Dominguez, J 

Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia 

EUR J CLIN MICROBIOL 2009-FEB; 28 (2): 197-201 

IF: 2,605 

Angi M, Romano V, Valldeperas X, Romano F, Romano MR 

Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient 

Int Ophthalmol Enero 2009 

Arcelus, JI; Cairols, M; Granero, X; Jimenez, D; Llau, JV; Monreal, M; Vicente, V 

New oral anticoagulants: A multidisciplinary approach 

MED CLIN-BARCELONA 2009 oct-10;133:508-512 


IF: 1,231 

Ardèvol M, Valera M, Hidalgo JA, Codina C, Alvarez L, Castillo I 

Impacto de la atención farmacéutica regulada sobre la respuesta virológica en HCC y la permanencia al tratamiento con 

peginterferón alfa 2a y ribavirina 

FARMACIA 2009; 33(suppl):11-2. 

IF: 0,144 

Arditi C, Gonvers JJ, Burnand B, Minoli G, Oertli D, Lacaine F, Dubois RW, Vader JP, Schusselé Filliettaz S, Peytremann-Bridevaux I, 

Pittet V, Juillerat P, Froehlich F; EPAGE II Study Group. 

Appropriateness of colonoscopy in Europe (EPAGE II). Surveillance after polypectomy and after resection of colorectal cancer. 


IF: 5,545 

Arditi C, Peytremann-Bridevaux I, Burnand B, Eckardt VF, Bytzer P, Agréus L, Dubois RW, Vader JP, Froehlich F, Pittet V, Schusselé 

Filliettaz S, Juillerat P, Gonvers JJ; EPAGE II Study Group. 

Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. 


IF: 5,545 

Arméstar F, Mesalles E, Font A, Arellano A, Roca J, Klamburg J, Fernández-Llamazares J 

Complicaciones postoperatorias tras esofaguectomía en el carcinoma esofágico 

MEDICINA INTENSIVA 2009;33: 224-32 

Arméstar F, Mesalles E, Manciño, Matas L 

SDRA secundario a Fiebre Botonosa Mediterránea 

MEDICINA INTENSIVA 2009;33:306 

Arzoz-Fabregas M, Ibarz-Servio L, Blasco-Casares FJ, Ramón-Dalmau M, Ruiz -Marcellán F.J. 

Can infundibular height predict the clearence of lower pole calyceal Stone after extracorporeal shockwave lithotripsy. 

INT J UROL 2009 Mar-Apr;35(2):140-9; discussion 149-50. 

IF: 1,158 

Barba, R; Bisbe, J; Pedrajas, JNA; Toril, J; Monte, R; Munoz-Torrero, JFS; Monreal, M 

Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA 

registry 

EUR J CARDIOV PREV R 2009-AUG; 16 (4): 457-463 

IF: 2,511 

Baz, JA; Albarran, A; Pinar, E; Mauri, J 

Spanish Cardiac Catheterization and Coronary Intervention Registry. 18(th) Official Report of the Spanish Society of Cardiology 

Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2008) 

REV ESP CARDIOL 2009; 62:1418-1434 

IF: 2,746 

Bernabeu M, Demirtas-Tatliede A, Opisso E, Lopez R, Tormos JM, Pascual-Leone A. 

Abnormal corticospinal excitability in traumatic diffuse axonal braininjury. 

J NEUROTRAUM 2009 Dec;26(12):2185-93 

IF: 4,252 

Bernabeu M, Laxe S, Lopez R, Stucki G, Ward A, Barnes M, Kostanjsek N, Reed G, Tate R, Whyte J, Zasler N, Cieza A. 

Developing core sets for persons with traumatic brain injury based on the international classification of functioning, disability, and 

healt 

NEUROREHAB NEURAL RE 2009 Jun; 23(5):464-7. 

IF: 5,398 

Blanco-Molina, A; Trujillo-Santos, J; Tirado, R; Canas, I; Riera, A; Valdes, M; Monreal, M 

Venous thromboembolism in women using hormonal contraceptives 

THROMB HAEMOSTASIS 2009-MAR; 101 (3): 478-482 

IF: 3,619 

Blasco, PB; Comas, JG; Del Alcazar Munoz R 


Spontaneous improvement of a haemodynamically significant ventricular septal defect produced by blunt chest trauma in a child 

CARDIOL YOUNG 2009-FEB; 19 (1): 109-110 

IF: 1,804 

Boada A, Carrascosa J, Leal L, Ferrándiz C. 

Generalized cutaneous drug eruption due to strontium ranelate 

J EUR ACAD DERMATOL 2009:23:321-22 (A) 

IF: 2,787 

Boix J, Lorenzo-Zúñiga V, Añaños F, Moreno de Vega V, Planas R. 

A 2-rooms-per-endoscopist model enhances efficiency in GI endoscopy. 

GASTROINTEST ENDOSC 2009 Nov;70(5):1047-8; author reply 1048-9. 

IF: 6,713 

Boix, J; Lorenzo-Zuniga, V; de Vega, VM; Domenech, E; Gassull, MA 

Endoscopic resection of ampullary tumors: 12-year review of 21 cases 

SURG ENDOSC 2009-JAN; 23 (1): 45-49 

IF: 3,307 

Boix, J; Lorenzo-Zuniga, V; de Vega, VM; Planas, R 

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection in Patients with Dysplastic Barrett's Esophagus 

DIGEST DIS SCI 2009-AUG; 54 (8): 1808-1809 

IF: 1,838 

Bolognini N, Pascual-Leone A, Fregni 

Using non-invasive brain stimulation to augment motor training-induced plasticity. 

J NEUROENG REHABIL 2009 Mar 17;6:8. 

IF: 2,115 

Bonafont X, Bock A, Carter D, Brunkhorst R, Carrera F, Iskedjian M, Molemans B, Dehmel B, Robbins SA 

A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis 

NDT PLUS 2009; 2:347-53 

Bonafont X, Bonal J 

Dosificación de medicamentos en la insuficiencia renal 

SEMIN FUND ESP REUMATOL 2009;10:24-8. 

Bonafont, X; Perez, A; Ardevol, M; Perez, C; Bonal, J; Romero, R 

Acceptance and self-administration rate of a new administration form of darbepoetin alfa (SureClick) in predialysis chronic kidney 

disease patients 

PHARM WORLD SCI 2009-FEB; 31 (1): 41-41 

IF: 0,919 

Bosch M, Bonafont X 

Efecte de l´ ús de plantes medicinals en el perioide perioperatori 

Butlletí d’Informació Terapèutica 2009;21:19-24 

Bosch M, Mazo V, Areny J, Sala F, Cardona G, Bonafont X 

Uso de plantas medicinales antes de la cirugía 

FARMACIA 2009; 33(suppl):47-8. 

IF: 0,144 

Camps, I; Armestar, F; Cuadrado, M; Mesalles, E 

VAC (vacuum-assisted closure) "covered" laparostomy to control abdominal compartmental syndrome in a case of 

emphysematous pancreatitis 

CIRUGIA ESPANOLA 2009 OCT;86:250-251 

Canet, J; Vila, E; Guasch, RG 

Comments on "Anesthesia in Thoracic Surgery in Catalonia: Results of a Survey Carried Out in 2003" Reply 

ARCH BRONCONEUMOL 2009-AUG; 45 (8): 413-414 

IF: 2,166 


Cardona G, Bosch M, Costa J, Planas R, Bonafont X. 

Prescripció de fàrmacs en insuficiència hepàtica. 

Butlletí del Medicament 2009;11(49):1-6. 

Cardona, G; Galan, A; Alvarez, M; Perez, C; Giner, P; Bonafont, X 

Do we need any alerts in electronic prescription of drugs that induce hyperkaliemia 

PHARM WORLD SCI 2009-APR; 31 (2): 300-300 

IF: 0,919 

Carretro A., Sanchez Planell L., Rusiñol Estragués J., Raich escursell R., Sanchez Carracedo D. 

Relevancia de factores de riesgo, psicopatología alimentaria, insatisfacción corporal y funcionamiento psicológico en pacientes 

con TCA 

CLINICA Y SALUD 2009,20(2):145-157. 

Castaño B, Benito J, Pires F, Ferreira S, Lopez R, Vidal J. 

Delirium secondary to intrathecal baclofen. 

SPINAL CORD 2009 Jun;47(6):477-80. 

IF: 1,783 

Castellanos, J; Garcia-Nuno, L; Cavanilles-Walker, JM; Roca, J 

Iatrogenic Femoral Neck Fracture During Closed Nailing of the Femoral Shaft Fracture 

EUR J TRAUMA EMERG S 2009 OCT;35:479-481 

IF: 0,207 

Cohen-Solal A, Kotecha D, van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M; 

SENIORS Investigators. (Valle, Lupón) 

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. 

EUR J HEART FAIL 2009 Sep;11(9):872-80. Epub 2009 Aug 1. 

IF: 3,706 

Comajuan, SM; Lopez-Ayerbe J; Ferrer, BR; Quer, C; Camazon, NV; Sistach, EF; Capllonch, FG; Baliarda, XR; Valle V 

An intracardiac ectopic thyroid mass 

EUR J ECHOCARDIOGR 2009-JUL; 10 (5): 704-706 

IF: 1,476 

Comisión Nacional de la Especialidad de Anestesiología y Reanimación: Navia J, Monedero P, Echevarría M, Canet J, Aguilera L, 

Herreras JI, Gómez M, Puig M, Abengoechea JM, Hernández J, Romero AJ. 

Guidelines on clinical rotation periods for medical residents in anesthesiology and postanesthesia recovery care. 

Rev Esp Anestesiol Reanim 2009 Dec; 56(10):589 

Curós A, Ribas N, Baz J.A., Serra J., E. Fernández Nofrerias, O. Rodriguez, Valle V. 

Estrategias para reducir el tiempo de reperfusión en el tratamiento con angioplastia primaria 

REV ESP CARDIOL 2009;9:34C-45C 

IF: 2,746 

Dal-Re, R; Costa, J 

Informing participants on study results and the Declaration of Helsinki 2008 

MED CLIN-BARCELONA 2009-MAY 23; 132 (19): 763-764 

IF: 1,231 

Díez J, Coca A, de Teresa E, Anguita M, Castro-Beiras A, Conthe P, Cobo E, Fernández E; TORAFIC Investigators Group. (Lupón) 

TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure 

Expert Rev Cardiovasc Ther 2009 Aug;7(8):897-904. 

Domenech J, Tormos JM, Barrios C, Pascual-Leone A. 

Motor cortical hyperexcitability in idiopathic scoliosis: could foca1 dystonia be a subclinical etiological factor 

EUR SPINE J 2009 Dec 24. 

IF: 1,956 

Domingo, M; Gil, O; Serrano, E; Guirado, E; Nofrarias, M; Grassa, M; Caceres, N; Perez, B; Vilaplana, C; Cardona, PJ 

Effectiveness and Safety of a Treatment Regimen Based on Isoniazid Plus Vaccination with Mycobacterium tuberculosis cells' 


Fragments: Field-Study with Naturally Mycobacterium caprae-Infected Goats 

SCAND J IMMUNOL 2009; 69:500-507 

IF: 2,108 

E. Amestoy, A. Segura, H. Guardiola, A. Carreres. 

Síndrome de hiperestimulación ovárica en una mujer de 19 años. 

MED CLIN-BARCELONA 2009 

IF: 1,231 

Evangelista, A; Padilla, F; Lopez-Ayerbe, J; Calvo, F; Lopez-Perez, JM; Sanchez, V; Moris, C; Fernandez-Tarrio, R; Roman, 

JAS; Saura, D; Nistal, F; Alegret, JM; Gallego, P; Aguilar, R 

Spanish Acute Aortic Syndrome Study (RESA). Better Diagnosis Is Not Reflected in Reduced Mortality 

REV ESP CARDIOL 2009-MAR; 62 (3): 255-262 

IF: 2,746 

Ferrer A, Estrada MD, Borràs A, Espallargues M. 

Guía para la indicación de la densitometría ósea en la valoración del riesgo de fractura y el control evolutivo de la osteoporosis. 

MED CLIN-BARCELONA 2009; 132(11): 428-436. 

IF: 1,231 

Filliettaz, SS; Gonvers, JJ; Peytremann-Bridevaux, I; Arditi, C; Delvaux, M; Numans, ME; Lorenzo-Zuniga, V; Dubois, RW; Juillerat, P; 

Burnand, B; Pittet, V; Vader, JP; Froehlich, F 

Functional bowel disorders: pain, constipation and bloating 

ENDOSCOPY 2009-MAR; 41 (3): 234-239 

IF: 5,545 

Fiz, JA; Prat, JM; Jane, R 

Treatment of Patients With Simple Snoring 

ARCH BRONCONEUMOL 2009 OCT;45:508-515 

IF: 2,166 

Friguls B, Coroleu W, del Alcazar R, Hilbert P, Van Maldergem L, Pintos-Morell G. 

Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation. 

EUR J MED GENET 2009 Jan-Feb;52(1):14-6. Epub 2008 Nov 12. 

IF: 1,568 

Fuster D, Torrens M, Tor J, Muga R 

Paciente con abuso de alcohol, infección por el VIH y hepatitis crónica C 

Trastornos adictivos 2009;11(3):173-9 

Galanaud JP, Quenet S, Rivron-Guillot K, Quere I, Sanchez Muñoz-Torrero JF, Tolosa C, Monreal M; RIETE INVESTIGATORS. 

Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 

086 patients. 

J THROMB HAEMOST 2009 Dec;7(12):2028-34. Epub 2009 Sep 28.PMID: 19793188 

IF: 6,069 

Garcia M, Morillas RM,Miquel M, Rodriguez O, Cirera I, Vergara M,Masnou H, Gimenez MD, Cañete N, Gallach M, Ardèvol M, 

Alvarez MA, Montoliu S, Romero M, Planas R, Solá R. 

Analysis of causes of response failure in naive patients with chronic hepatitis C receiving peginterferon plus ribavirin 

HEPATOLOGY 2009, 50(supll):A896 

IF: 10,840 

García-Melchor E 

Problemas de los residentes: ¿cómo podemos solucionarlos) 

SEMIN FUN ESP REUMATOL 2009; 10 (3): 100-103. 

Garcia-Olive, I; Forcada, EV; Garcia, FA; Sanz-Santos, J; Castella, E; Llatjos, M; Astudillo, J; Monso, E 

Linear Endobronchial Ultrasound as the Initial Diagnostic Tool in Patients With Indications of Mediastinal Disease 

ARCH BRONCONEUMOL 2009-JUN; 45 (6): 266-270 

IF: 2,166 


Garcia-Pagan, JC; Villanueva, C; Albillos, A; Banares, R; Morillas, R; Abraldes, JG; Bosch, J 

Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre 

randomised controlled trial 

GUT 2009-AUG; 58 (8): 1144-1150 

IF: 9,357 

Gayol MC,Font A,Casas I,Estrada O, Domínguez MJ, Pedro-Botet ML 

Utilidad de la escala de MASCC en el tratamiento de la neutropenia febril inducida por quimioterapia en pacientes con neopasia 

sólida 

MED CLIN-BARCELONA 2009;133(8):296–299 

IF: 1,231 

Gomar Sancho C, Montero Matamala A, Puig Riera de Conias M, Sabaté Pes A, Fábregas Juliá N, Valero Castell R, Dalmau Llitjos A, 

Rull Bartomeu M, García Guasch R, Fita Rodríguez G, Rovira Canudas I, Gallart Gallego L, Samsó Sabé E, Villalonga Vadell R, 

Vilanova Cardena F, Koo Gómez M, Roigé Solé J, de Nadal Clanchet M, Añez Simón C, Villalonga, Morales A, Roldán Osuna J, Díaz 

Meco FX. 

A proposal for competencies in anethesiology, intensive recovery care, and pain therapy: the consensus of university faculty 

members in Catalonia regarding expectations for medical school graduates. 

Rev Esp Anestesiol Reanim 2009 Aug-Sep;56(7):436-44. 

Gonzalez Wellens N, Minguez S,Lozano M,Olivé A 

Neuripatía del trigémino y dermatomiositis 

MED CLIN-BARCELONA 2009; Jun 9. pmid: 19520399 

IF: 1,231 

Grau J, Formiga F, Jordana R, Urrutia A, Arias JL, Salvador J 

Etiología y tratamiento de la anemia en la insuficiencia cardíaca. Estudio GESAIC. 

MED CLIN-BARCELONA 2009;132:447-53 

IF: 1,231 

Heras, E; Salas, RM; Capdevila, JA 

A patient from Maghreb with dysphagia 

MED CLIN-BARCELONA 2009-SEP 19; 133 (10): 397-401 

IF: 1,231 

Hernández C, Serra J. 

Acalasia: ¿Tratamiento definitivo o retratamiento seguro 

ANN MED 2009; 92:S1-89. 

IF: 4,246 

Ibarz L; Fabregas, MA; Dominguez, JMR; Massana, MB; Sanz, JLM; Roig, JMS 

Primary lymphoma of penis 

ACTAS UROLOGICAS ESPANOLAS 2009-JUL-AUG; 33 (7): 826-829 

Ibarz Servio L, Ruiz Domínguez J, Cannata Ortiz P, Olazabal Zudaire A. 

Oncocitoma renal gigante. 

MED CLIN-BARCELONA 2009; 132: 527. 

IF: 1,231 

Jimenez, D; Uresandi, F; Otero, R; Lobo, JL; Monreal, M; Marti, D; Zamora, J; Muriel, A; Aujesky, D; Yusen, RD 

Troponin-Based Risk Stratification of Patients With Acute Nonmassive Pulmonary Embolism Systematic Review and Metaanalysis 

CHEST 2009 OCT;136:974-982 

IF: 6,360 

Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U, 

Tincheva R, Wraith JE; HOS Investigators. (Pintos G) 

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter 

Outcome Survey (HOS). 

J INHERIT METAB DIS 2009 Aug;32(4):534-43. Epub 2009 Jul 14. 

IF: 3,598 

Just S, Torrabadella P, Campos A, Fabra M 


Cirugía cardiaca en octogenarios 

MED CLIN-BARCELONA 2009; 133: 76-78 

IF: 1,231 

Kofler M, Kumru H, Stetkarova 1, Rüegg S, Fuhr P, Leis AA. 

Cutaneous silent periods are not affected by the antihistaminic drug cetirizine. 

CLIN NEUROPHYSIOL May;120(5):1016-9. 

IF: 3,122 

Kolb, S; Wengenroth, L; Hege, I; Praml, G; Nowak, D; Cantineau, J; Cantineau, A; Gonzalez, M; Monso, E; Pauncu, EA; Vellore, AD; 

Godnic-Cvar, J; Radon, K 

Case Based e-Learning in Occupational Medicine-A European Approach 

J OCCUP ENVIRON MED 2009; 51:647-653 

IF: 1,882 

Kumru H, Kofler M, Valls-Solé J, Portell E, Vidal J. 

Brainstem reflexes are enhanced following severe spinal cord injury and reduced by continuous intrathecal baclofen. 

NEUROREHAB NEURAL RE 2009 Nov;23(9):921-7. 

IF: 5,398 

Kumru H, Opisso E, Valls-Solé J, Kofler M. 

The effect of a prepulse stimulus on the EMG rebound following the cutaneous silent period. 

J PHYSIOL-LONDON 2009 Feb 1 ;587(Pt 3):587-95. 

IF: 4,764 

Kumru H, Vidal J, Perez M, Schestatsky P, Valls-Solé J. 

Sympathetic skin responses evoked by different stimuli modalities in spinal cord injury patients. 

NEUROREHAB NEURAL RE 2009 Ju1;23(6):553-8 

IF: 5,398 

Kuna, P; Bachert, C; Nowacki, Z; van Cauwenberge, P; Agache, I; Fouquert, L; Roger, A; Sologuren, A; Valiente, R 

Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of 

seasonal allergic rhinitis: a randomized, double-blind, parallel-group study 

CLIN EXP ALLERGY 2009-SEP; 39 (9): 1338-1347 

IF: 4,084 

Lobo JL, Zorrilla V, Aizpuru F, Grau E, Jiménez D, Palareti G, Monreal M; RIETE Investigators. 

D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry. 

J THROMB HAEMOST 2009 Nov;7(11):1795-801. Epub 2009 Aug 19.PMID: 19691481 

IF: 6,069 

Lorenzo-Zuniga, V; De Vega, VM; Domenech, E; Boix, J 

Diagnosis and treatment of ampullary tumors 

Gastroenterologia y hepatologia 2009-FEB; 32 (2): 101-108 

Lorenzo-Zuniga, V; de Vega, VM; Moreno, P; Muchard, J; Boix, J 

Endoscopic placement of postpyloric nasoenteric feeding tubes: The importance of the guidewire used 

CLIN NUTR 2009-JUN; 28 (3): 355-356 

IF: 3,274 

Lorenzo-Zúñiga V, de Vega VM, Doménech E, Mañosa M, Planas R, Boix J. 

Endoscopist experience as a risk factor for colonoscopic complications 

COLORECTAL DIS 2009 Nov 23. [Epub ahead of print] 

IF: 2,410 

Lorenzo-Zúñiga V, V.Moreno de Vega, E.Domènech, J.Boix. 

Diagnóstico y tratamiento de los tumores de papila de Vater. 

Gastroenterol Hepatol 2009; 32: 101-108. 

Loscos-Arenas J, De-La-Cámara J. 

Blindness in the works of E. Sábato: information on the blind. 


Arch Soc Esp Oftalmol 2009 Mar;84(3):163-4. Spanish. 

Lucas-Martin AM 

Postpartum thyroiditis: Must we do sreenning 

MED CLIN-BARCELONA 2009-APR 25; 132 (15): 585-586 

IF: 1,231 

Lucena MI, Andrade RJ, Kaplowitz N, García-Cortes M, Fernández MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, 

Rodriguez-González JF, Navarro JM, Salmeron J, Martinez-Odriozola P, Pérez-Alvarez R, Borraz Y, Hidalgo R; Spanish Group for the 

Study of Drug-Induced Liver Disease. 

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. 

HEPATOLOGY 2009 Jun;49(6):2001-9. 

IF: 10,840 

Martin PI, Naeser MA, Ho M, Doron KW, Kurland J, Kaplan J, Wang Y, Nicholas M, Baker EH, Fregni F, Pascual-Leone 

Overt naming fMRl preand post-TMS: Two nonfluent aphasia patients, with and without improved naming post-TMS 

BRAIN LANG 2009 Oct; 1 1 l(1) 

IF: 2,973 

Martinez, SJ; Torrabadella de Reynoso P; Radua, ACGF 

Octogenarians undergoing cardiac surgery 

MED CLIN-BARCELONA 2009-juny-13; 133 (2): 76-76 

IF: 1,231 

Mateo L, Olivé A, Garcia-Casares E, Garcia-Melchor E, Holgado S, Tena X 

Artritis séptica politópica: análisis de 19 casos. 

Reumatología Clínica 2009; 5 (1): 18-22 

Mehta A, Beck M, Elliott P, Giugliani R, Linhart A, Sunder-Plassmann G, Schiffmann R, Barbey F, Ries M, Clarke JT; Fabry Outcome 

Survey investigators. 

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. 

LANCET 2009 Dec 12;374(9706):1986-96. 

IF: 30,758 

Moltó A, Holgado S, Mateo L, Olivé A 

Osteoporosis transitoria de la cadera y embarazo 

MED CLIN-BARCELONA 2009 Oct 21. pmid: 19853264 

IF: 1,231 

Monreal, M 

Towards a better prevention of venous thromboembolism 


IF: 1,231 

Montané E, Andreu A, Barriocanal AM, Bonafont X. 

Inadequate information in the medication orders of hospital inpatients. 

MED CLIN-BARCELONA 2009 Jul 29 

IF: 1,231 

Montane, E; Barriocanal, A; Isern, I; Parajon, T; Costa, J 

Multiple drug interactions - induced serotonin syndrome: a case report 

J CLIN PHARM THER 2009-AUG; 34 (4): 485-487 

IF: 1,671 

Morillas RM, Cirera I, García Retortillo Mª, Masnou H, Miquel M, Ardèvol M, Coll S, Bory F, Planas R, Solà R 

Eficacia de l’adefovir en l’hepatitis B HbeAg en la pràctica clìnica 

ANN MED 2009; 92 (Suppl 1) 

IF: 4,246 

Negredo, E; Puig, J; Aldea, D; Medina, M; Estany, C; Perez-Alvarez, N; Rodriguez-Fumaz, C; Munoz-Moreno, JA; Higueras, C; 

Gonzalez-Mestre, V; Clotet, B 

Four-Year Safety with Polyacrylamide Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy 


AIDS RES HUM RETROV 2009; 25:451-455 

IF: 2,178 

Nitsche MA, Boggio PS, Fregni F, Pascual-Leone A. 

A. Treatment of depression with transcranial direct current stimulation (tDCS) 

EXP NEUROL 2009 

Sep;219(1). 

IF: 3,914 

Olivé A 

El gran momento de la Reumatología Española 

Reumatología Clínica 2009; 5: 187-188 

Olivé A, Garcia Melchor E 

A propósito del fenómeno de Raynaud 

MED CLIN-BARCELONA 2009 Dec 16. PMID: 20022066 

IF: 1,231 

Olivé A, Lisabeth K, Pereira da Silva JA 

El nuevo currículo europeo de reumatología. 

SEMIN FUN ESP REUMATOL 2009; 10 (3): 75. 

Olivé A. 

Who is afraid of the MIR system 


IF: 1,231 

Peyró R, Aguilera L, Barturen F, Canet J, Ginesta V, Gómez-Herreras JI, Monedero P, Navia J, Sánchez C. 

Merging the specialty of anesthesiology and postanesthesia recovery care medicine with intensive care medicine. 

Rev Esp Anestesiol Reanim 2009 Dec;56(10):628-31. 

Peytremann-Bridevaux I, Arditi C, Froehlich F, O'Malley J, Fairclough P, Le Moine O, Dubois RW, Gonvers JJ, Schusselé Filliettaz S, 

Vader JP, Juillerat P, Pittet V, Burnand B; EPAGE II Study Group. 

Appropriateness of colonoscopy in Europe (EPAGE II). Iron-deficiency anemia and hematochezia. 


IF: 5,545 

Pimienta M, Olivé A. 

El fenómeno de la patergia 

SEMIN FUN ESP REUMATOL 2009; 10 (3): 87-90. 

Pinar, E; Albarran, A; Baz, JA; Mauri, J 

Update on Interventional Cardiology 

REV ESP CARDIOL 2009-; 62: 101-116 

IF: 2,746 

Pintos-Morell G, Beck M. 

Fabry disease in children and the effects of enzyme replacement treatment. 

EUR J PEDIATR 2009 Nov;168(11):1355-63. Epub 2009 Feb 26. 

IF: 1,634 

Planas R, Morillas RM, Sala M. 

Prescripció de fàrmacs en la insuficiencia hepàtica. 

Butlletí d’Informació Terapèutica 2009; 21 (núm 5) 

Plauth, M; Cabre, E; Campillo, B; Kondrup, J; Marchesini, G; Schutz, T; Shenkin, A; Wendon, J 

ESPEN Guidelines on Parenteral Nutrition: Hepatology 

CLIN NUTR 2009-AUG; 28 (4): 436-444 

IF: 3,274 

Podlekareva D., J. Reekie, A. Rakhmanova, A. Horban, I. Karpov, P. Domingo, M. Losso, A.Mocroft, J. Lundgren, O. Kirk, and the 

EuroSIDA study group 


Differences in Health Care of HIV-infected patients across Europe. 

PLOS MED 2009 

IF: 13,050 

Puyalto P, Arméstar F, Cuadras P, Moreno JA 

Isquemia aguda del territorio de la arteria basilar 

MED CLIN-BARCELONA 2009; 1333: 268 

IF: 1,231 

Ripoll, C; Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, N; Burroughs, A; Planas, R; Escorsell, A; Garcia-Pagan, JC; Makuch, R; 

Patch, D; Matloff, DS 

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis 

J HEPATOL 2009-MAY; 50 (5): 923-928 

IF: 7,818 

Rivas, I; Latorre, I; Sanvisens, A; Dominguez, J; Tor, J; Prat, C; Rey-Joly, C; Muga, R 

Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers 

EPIDEMIOL INFECT 2009-SEP; 137 (9): 1342-1347 

IF: 2,365 

Roa L, Monreal M, Carmona JA, Aguilar E, Coll R, Suárez C; en representación del Grupo FRENA. 

Treatment inertia in secondary prevention of cardiovascular disease. Frena registry. 

MED CLIN-BARCELONA 2009 Nov 11. [Epub ahead of print] Spanish. PMID: 19913259 

IF: 1,231 

Roldan, V; Lecumberri, R; Munoz-Torrero, JFS; Vicente, V; Rocha, E; Brenner, B; Monreal, M 

Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry 

THROMB RES 2009-JUN; 124 (2): 174-177 

IF: 2,406 

Rosset-Llobet J, Candia V, Fabregas I Molas S, Dolors Rosinés 1, Cubells D, Pascual-Leone A. 

The challenge of diagnosing foca1 hand dystonia in musicians. 

EUR J NEUROL 2009 Jul;16(7):864-9 

IF: 2,510 

Ruiz-Almazan, I; Caceres, C; Plano, J; Cobo-Gomez, JV 

Neuropsychological profile in elderly people's musical hallucinations 

REV NEUROLOGIA 2009-MAY 1; 48 (9): 500-501 

IF: 1,234 

Sabate, S; Gomar, C; Huguet, J; Castillo, J; Canet, J; Villalonga, A 

Anesthesia for urological surgery in a European region with 6.7 million inhabitants (Catalonia, Spain) 

J CLIN ANESTH 2009-FEB; 21 (1): 30-37 

IF: 1,324 

Sánchez P, Tomasa TM, Catalán B, Martínez-Vega S, Gener J y Klamburg J 

“Hematoma epidural cervicotorácico espontáneo agudo” 

MEDICINA INTENSIVA 2009;33:54-7. 

Schusselé Filliettaz S, Gonvers JJ, Peytremann-Bridevaux I, Arditi C, Delvaux M, Numans ME, Lorenzo-Zúñiga V, Dubois RW, 

Juillerat P, Burnand B, Pittet V, Vader JP, Froehlich F; EPAGE II Study Group. 

Appropriateness of colonoscopy in Europe (EPAGE II). Functional bowel disorders: pain, constipation and bloating. 


IF: 5,545 

Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada JR. 

Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome. 

NEUROGASTROENT MOTIL 2009 Dec 28. [Epub ahead of print] 

IF: 3,568 

Solà R, Morillas RM, García Retortillo M, Cirera I, Vergara M, Masnou H, Jiménez MD, Gallach M, Ardèvol M, Álvarez MA, Montoliu 

S, Planas R 


Motius del fracàs del tractament de l’hepatitis C amb interferó pegilat i ribavirina 

ANN MED 2009; 92 (Suppl 1): S1-80 

IF: 4,246 

Soler X, Sell R, Maestre J, Ruiz-Manzano J 

Bronchial rupture by an unusual mechanism of thoracic hyperextension. 

J EMERG MED 2009 Apr 28. [Epub ahead of print] 

IF: 1,265 

Terré R, Mearin F. 

Resolution of tracheal aspiration afier the acute phase of stroke-related oropharyngeal Dysphagia. 

AM J GASTROENTEROL 2009 Apr; 1 04(4):923-32. 

IF: 6,012 

Terré R, Mearin F. 

Evolution of tracheal aspiration in severe traumatic brain injury-related oropharyngeal dysphagia: 1-year longitudinal follow-up 

study. 

NEUROGASTROENT MOTIL 2009 Apr;21(4):361-9. 

IF: 3,568 

Toro, R; Perez-Isla, L; Doxastaquis, G; Barba, MA; Gallego, AR; Pintos, G; Barbados, FJ; Mangas, A; Zamorano, JL 

Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy 

INT J CARDIOL 2009-feb-06; 132 (1): 38-44 

IF: 3,469 

Trujillo-Santos J, Ruiz-Gamietea A, Luque JM, Samperiz AL, Garcia-Bragado F, Todoli JA, Monreal M; RIETE Investigators. 

Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE 

Registry. 

THROMB RES 2009; 123 Suppl 2:S10-5.PMID: 19217463 

IF: 2,406 

Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga 

R, Planas R, Sirera G, Rey-Joly C, Clotet B. 

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency 

virus and hepatitis C virus. 

CLIN GASTROENTEROL H 2009 Mar;7(3):339-45. Epub 2008 Dec 3 

IF: 5,642 

Valles M, Rodríguez A, Borau A, Mearin F. 

Effect of sacra1 anterior root stimulator on bowel dysfunctíon in patients with spinal cord injury. 

DIS COLON RECTUM 2009 May;52(5):986-92. 

IF: 2,536 

Van Gossum, A; Cabre, E; Hebuterne, X; Jeppesen, P; Krznaric, Z; Messing, B; Powell-Tuck, J; Staun, M; Nightingale, J 

ESPEN Guidelines on Parenteral Nutrition: Gastroenterology 

CLIN NUTR 2009-AUG; 28 (4): 415-427 

IF: 3,274 

Vasco, B; Villalba, JC; Lopez-Jimenez, L; Falga, C; Montes, J; Trujillo-Santos, J; Monreal, M 

Venous thromboembolism in nonagenarians Findings from the RIETE Registry 

THROMB HAEMOSTASIS 2009-JUN; 101 (6): 1112-1118 

IF: 3,619 

Vilaplana C, Montané E, Pinto S, Barriocanal AM, Domenech G, Torres F, Cardona PJ, Costa J. 

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTIâ. 

VACCINE 2009 Oct 22. 

IF: 3,616 

Vilaplana C., Cardona PJ 

Tuberculin immunotherapy: its history and lessons to be learned. 

MICROBES INFECT 2009; 1e7 

IF: 2,757 



Alvarez, J; Dominguez, A; Sabria, M; Ruiz, L; Torner, N; Cayla, J; Barrabeig, I; Sala, MR; Godoy, P; Camps, N; Minguell, S 

Impact of the Legionella urinary antigen test on epidemiological trends in community outbreaks of legionellosis in 

Catalonia, Spain, 1990-2004 

INT J INFECT DIS 2009; 13:E365-E370 

IF: 2,167 

Gieselmann V, Pintos-Morell G. 

Disease pathogenesis--basic science. 

INT J CLIN PHARM TH 2009;47 Suppl 1:S7-8. 

IF: 1,381 

Lopez, R; Poy, R; Pastor, MC; Segarra, P; Molto, J 

Cardiac defense response as a predictor of fear learning 

INT J PSYCHOPHYSIOL 2009; 74:229-235 

IF: 4,906 

Richard E, Jorge-Finnigan A, Garcia-Villoria J, Merinero B, Desviat LR, Gort L, Briones P, Leal F, Pérez-Cerdá C, Ribes A, Ugarte M, 

Pérez B; MMACHC Working Group. (Pintos G) 

Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with 

homocystinuria (MMACHC). 

HUM MUTAT 2009 Nov;30(11):1558-66. 

IF: 6,887 

Santin, S; Garcia-Maset, R; Ruiz, P; Gimenez, I; Zamora, I; Pena, A; Madrid, A; Camacho, JA; Fraga, G; Sanchez-Moreno, A; Cobo, 

MA; Bernis, C; Ortiz, A; de Pablos, AL; Pintos, G; Justa, ML; Hidalgo-Barquero, E; Fernandez-Llama, P; Ballarin, J; Ars, E; Torra, 

RFSGS Spanish Study Grp 

Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis 

KIDNEY INT 2009 DEC;76:1268-1276 

IF: 6,193 

Ventura Orriols E., Biosca Adzet C., Bayés Genís B., Holgado Pérez S., Lauzurica Valdemoros R., Corominas Vilardell A. 

Utilidad del propéptido amino-terminal del procolágeno tipo 1 (P1NP) como marcador de remodelado óseo en el paciente 

sometido a trasplante renal 

REV LAB CLIN 2009; 2:80-86. 

Projectes 


MOLTO MARHUENDA, JOSE - FUNDACIÓ LLUITA CONTRA LA SIDA 

Ministerio de Sanidad y Politica Social - Núm. Exp.: TRA-084 

Interacciones farmacológicas entre Echinacea Purpurea y Darunavir/Ritonavir. 

Durada: 1 anys - (2009-2010) 



ANDREO GARCIA, FELIPE CRISTOBAL - PNEUMOLOGIA 


Rentabilidad diagnóstica de la ultrasonografía endobronquial en el diagnóstico y estadificación del carcinoma pulmonar no 

microcítico. 

Durada: 3 anys - (2007-2010) 


COSTA PAGES, JOAN - FARMACOLOGIA CLÍNICA 


FIS - Núm. Exp.: EC08/00266 

Estudio prospectivo multicéntrico de la incidencia, relevancia clínica, factores de riesgo y preventibilidad del ingreso hospitalario 

por fracaso renal agudo asociado al uso de fármacos inhibidores del sistema renina-angiotensina. 

Durada: 3 anys - (2008-2011) 


ESTEBAN OLIVA, DOLORS - PEDIATRIA 

Fundación Santiago DEXEUS Font - Núm. Exp.: 

Estudio del patrón proteómico urinario en recién nacidos con anomalías nefro-urológicas de detección prenatal: búsqueda de 

biomarcadores predictores de la evolución. 

Durada: 2 anys - (2008-2010) 


FERRA COLL, CHRISTELLA MARIE - HEMATOLOGIA I HEMOTERÀPIA 


Relación de los valores séricos de la procalcitonina (PCT) y otros reactantes de fase aguda con las complicaciones y supervivencia 

de pacientes con hemopatías malignas que requieren ingreso en Unidad de Cuidados Intensivos. 

Durada: 3 anys - (2007-2010) 


FERRER LASALA, MARIA JOSE - MEDICINA INTERNA - VIH 

FIPSE - Núm. Exp.: 24673/07 

Elaboración y validación de un instrumento breve para la evaluación del funcionamiento neurocognitivo y motor en pacientes 

infectados por el VIH. 

Durada: 2 anys - (2007-2009) 


IBARZ SERVIO, LUIS - UROLOGIA 

Asociación Española de Urología - Núm. Exp.: -- 

El estrés crónico como factor etiológico de la litiasis renal oxalocálcica. Estudio de sus implicaciones psicológicas y posibles 

interacciones bioquímicas. 

Durada: 2 anys - (2008-2010) 


MILLAN TORNE, MONICA - NEUROLOGIA 

FIS - Núm. Exp.: EC07/90325 

Estudio doble ciego, aleatorizado, controlado con placebo de dosis escaladas de deferoxamina intravenosa en pacientes con ictus 

isquémico agudo tratado con activador tisular del plasminógeno. 

Durada: 3 anys - (2007-2010) 


MONREAL BOSCH, MANEL - MEDICINA INTERNA - HOSPITALITZACIÓ 


Predicción de la muerte por embolia pulmonar en España. 

Durada: 3 anys - (2008-2011) 



COMISSIÓ EUROPEA - Núm. Exp.: 135281-LLP-2007-1-DE-KA4MP 

NetWoRM-Net 3, Teaching in Work-Related Medicine. 

Durada: 2 anys - (2007-2009) 


MONTANÉ ESTEVA, EVA - FARMACOLOGIA CLÍNICA 

FIS - Núm. Exp.: EC07/90318 

Estudio de utilización de antifúngicos sistémicos en los hospitales españoles. 

Durada: 2 anys - (2007-2009) 


MORILLAS CUNILL, ROSA MARIA - APARELL DIGESTIU 

FIS - Núm. Exp.: EC08/00259 

Estudio multicéntrico, aleatorizado, doble-ciego, controlado con placebo, sobre la eficacia del tratamiento con beta-bloqueantes 


(nadolol o carvedilol según respuesta hemodinámica) para la prevención de la descompensación en pacientes con cirrosis 

compensada y gradiente de presión portal superior a 10 mmHg. 

Durada: 3 anys - (2008-2011) 


RAMO TELLO, CRISTINA - NEUROLOGIA 

FIS - Núm. Exp.: EC07/90278 

Ensayo clínico, multicéntrico, con asignación aleatoria y doble ciego, para comparar la eficacia clínica y radiológica de dosis 

equivalentes de metilprednisolona administradas por vía oral o vía intravenosa en pacientes en brote de esclerosis múltiple. 

Durada: 3 anys - (2007-2010) 



COLL CANTI, JAUME - NEUROLOGIA 


Paràlisi del malalt crític: Estudi Clínic, electrofisiològic, bioquímic i patològic. 

Durada: 3 anys - (2007-2010)

ANNEX 3 Linies.pdf - FundaciÃ³ Institut d'InvestigaciÃ³ en CiÃ¨ncies de ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?